<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="preprint">
<?all-math-mml yes?>
<?use-mml?>
<?origin ukpmcpa?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">bioRxiv</journal-id>
<journal-title-group>
<journal-title>bioRxiv : the preprint server for biology</journal-title>
</journal-title-group>
<issn pub-type="ppub"/>
</journal-meta>
<article-meta>
<article-id pub-id-type="manuscript">EMS103742</article-id>
<article-id pub-id-type="doi">10.1101/2020.11.03.367516</article-id>
<article-id pub-id-type="archive">PPR234508</article-id>
<article-version article-version-type="publisher-id">3</article-version>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The translational landscape of SARS-CoV-2 and infected cells</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Puray-Chavez</surname>
<given-names>Maritza</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lee</surname>
<given-names>Nakyung</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tenneti</surname>
<given-names>Kasyap</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Yiqing</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vuong</surname>
<given-names>Hung R.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Yating</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Horani</surname>
<given-names>Amjad</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Huang</surname>
<given-names>Tao</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gunsten</surname>
<given-names>Sean P.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Case</surname>
<given-names>James B.</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Wei</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Diamond</surname>
<given-names>Michael S.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Brody</surname>
<given-names>Steven L.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dougherty</surname>
<given-names>Joseph</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Kutluay</surname>
<given-names>Sebla B.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Department of Molecular Microbiology, Washington University School of Medicine, Saint Louis, MO 63110, USA</aff>
<aff id="A2">
<label>2</label>Department of Genetics, Washington University School of Medicine, Saint Louis, MO 63110, USA</aff>
<aff id="A3">
<label>3</label>Department of Pediatrics, Allergy, Immunology and Pulmonary Medicine, Washington University School of Medicine, Saint Louis, MO 63110, USA</aff>
<aff id="A4">
<label>4</label>Department of Medicine, Pulmonary and Critical Care Medicine, Washington University School of Medicine, Saint Louis, MO 63110, USA</aff>
<aff id="A5">
<label>5</label>Department of Medicine, Infectious Disease Division, Washington University School of Medicine, Saint Louis, MO 63110, USA</aff>
<aff id="A6">
<label>6</label>Department of Pathology &amp; Immunology, Washington University School of Medicine, Saint Louis, MO 63110, USA</aff>
<aff id="A7">
<label>7</label>Department of Psychiatry, Washington University School of Medicine, Saint Louis, MO 63110, USA</aff>
<author-notes>
<corresp id="CR1">Correspondence: <email>Kutluay@wustl.edu</email>
</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>10</day>
<month>11</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="preprint">
<day>05</day>
<month>11</month>
<year>2020</year>
</pub-date>
<permissions>
<ali:free_to_read/>
<license>
<ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref>
<license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND 4.0 International license</ext-link>.</license-p>
</license>
</permissions>
<abstract>
<p id="P1">SARS-CoV-2 utilizes a number of strategies to modulate viral and host mRNA translation. Here, we used ribosome profiling in SARS-CoV-2 infected model cell lines and primary airway cells grown at the air-liquid interface to gain a deeper understanding of the translationally regulated events in response to virus replication. We find that SARS-CoV-2 mRNAs dominate the cellular mRNA pool but are not more efficiently translated than cellular mRNAs. SARS-CoV-2 utilized a highly efficient ribosomal frameshifting strategy in comparison to HIV-1, suggesting utilization of distinct structural elements. In the highly permissive cell models, although SARS-CoV-2 infection induced the transcriptional upregulation of numerous chemokines, cytokines and interferon stimulated genes, many of these mRNAs were not translated efficiently. Impact of SARS-CoV-2 on host mRNA translation was more subtle in primary cells, with marked transcriptional and translational upregulation of inflammatory and innate immune responses and downregulation of processes involved in ciliated cell function. Together, these data reveal the key role of mRNA translation in SARS-CoV-2 replication and highlight unique mechanisms for therapeutic development.</p>
</abstract>
<kwd-group>
<kwd>SARS-CoV-2</kwd>
<kwd>ribosome profiling</kwd>
<kwd>ribo-seq</kwd>
<kwd>mRNA translation</kwd>
<kwd>virus replication</kwd>
<kwd>ribosomal frameshifting</kwd>
<kwd>virus-host interaction</kwd>
<kwd>immune response</kwd>
<kwd>translational repression</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="intro">
<title>Introduction</title>
<p id="P2">The Coronavirus (CoV) group encompasses of a number of single-stranded, positive-sense RNA viruses with unusually large genomes (27-32 kb), which infect a wide range of animal species, including humans (<xref ref-type="bibr" rid="R54">Masters, 2006</xref>, <xref ref-type="bibr" rid="R79">Weiss and Navas-Martin, 2005</xref>). Presently, SARS-CoV-2, the causative agent of the ongoing Coronavirus Disease-2019 (COVID-19) pandemic, continues to spread around the globe in part due to the emergence of viral variants with enhanced ability to transmit. Despite the high degree of protection with the SARS-CoV-2 vaccines, vaccine access remains limited globally. Furthermore there are limited options for antiviral or immunomodulatory treatment against SARS-CoV-2. A basic understanding of the replicative mechanisms of SARS-CoV-2 and associated host responses in relevant settings can foster the development of virus-specific therapies.</p>
<p id="P3">SARS-CoV-2 induced lung disease is thought to be in part due to manipulation of host type-I interferon (IFN) signaling (<xref ref-type="bibr" rid="R70">Sa Ribero et al., 2020</xref>). Compared to other CoVs such as SARS-CoV and Middle East respiratory syndrome (MERS), SARS-CoV-2 induces a poor or delayed IFN response in various experimental settings and <italic>in vivo</italic> (<xref ref-type="bibr" rid="R7">Blanco-Melo et al., 2020</xref>, <xref ref-type="bibr" rid="R89">Zhang et al., 2020</xref>, <xref ref-type="bibr" rid="R53">Lokugamage et al., 2020</xref>). Extensive characterization of SARS-CoV-2-encoded proteins within the past year has revealed multiple ways in which SARS-CoV-2 can post-transcriptionally manipulate host gene expression and induction of innate immune responses. For example SARS-CoV-2 NSP1, NSP6, NSP13, ORF3a, M, ORF7a and ORF7b inhibit STAT1/2 phosphorylation and ORF6 can inhibit STAT1 nuclear translocation (<xref ref-type="bibr" rid="R70">Sa Ribero et al., 2020</xref>, <xref ref-type="bibr" rid="R48">Lei et al., 2020</xref>, <xref ref-type="bibr" rid="R40">Konno et al., 2020</xref>, <xref ref-type="bibr" rid="R56">Miorin et al., 2020</xref>, <xref ref-type="bibr" rid="R83">Xia et al., 2020</xref>). NSP1 additionally binds to the mRNA entry channel of the 40S ribosomal subunit as well as non-translating 80S ribosomes to prevent binding of capped mRNA and thus inhibit the formation of the translation initiation complex (<xref ref-type="bibr" rid="R72">Schubert et al., 2020</xref>, <xref ref-type="bibr" rid="R1">Banerjee et al., 2020</xref>, <xref ref-type="bibr" rid="R76">Thoms et al., 2020</xref>, <xref ref-type="bibr" rid="R46">Lapointe et al., 2021</xref>). Furthermore, NSP16-mediated inhibition of alternative mRNA splicing has been implicated in suppression of innate immune responses (<xref ref-type="bibr" rid="R1">Banerjee et al., 2020</xref>). Under such inhibitory conditions SARS-CoV-2 mRNAs are thought to be efficiently translated owing to the structured elements within the 5’UTRs of viral mRNAs (<xref ref-type="bibr" rid="R77">Tidu et al., 2020</xref>, <xref ref-type="bibr" rid="R1">Banerjee et al., 2020</xref>, <xref ref-type="bibr" rid="R21">Finkel et al., 2021</xref>). On the other hand, the bulk of published research on SARS-CoV- and SARS-CoV-2-host interactions has relied on transcriptional profiling to study the immune response to infection (<xref ref-type="bibr" rid="R7">Blanco-Melo et al., 2020</xref>, <xref ref-type="bibr" rid="R9">Butler et al., 2020</xref>, <xref ref-type="bibr" rid="R55">Menachery et al., 2014</xref>, <xref ref-type="bibr" rid="R57">Mitchell et al., 2013</xref>, <xref ref-type="bibr" rid="R80">Wilk et al., 2020</xref>, <xref ref-type="bibr" rid="R90">Zhou et al., 2020</xref>). Such approaches may not fully capture the host immune response to infection, in the face of viral mechanisms that block host mRNA translation.</p>
<p id="P4">In addition to manipulation of host mRNA translation, SARS-CoV-2 utilizes programmed ribosomal frameshifting to successfully launch infection. The first two-thirds of the 5’ end of the SARS-CoV-2 genome is composed of two overlapping open reading frames (ORFs), ORF1a and ORF1b, which encode for two polyproteins, pp1a and pp1ab (<xref ref-type="bibr" rid="R59">Nakagawa et al., 2016</xref>). Pp1a is produced when translation of the genomic RNA terminates at the stop codon of ORF1a. Pp1ab is generated via a programmed -1 ribosomal frameshift (PRF) that occurs at the overlap between ORF1a and ORF1b, permitting the elongating ribosomes to bypass the termination signal in ORF1a (<xref ref-type="bibr" rid="R63">Plant and Dinman, 2008</xref>). Following synthesis, pp1a and pp1ab are cleaved by viral proteases to generate 15-16 mature nonstructural proteins (NSPs) (<xref ref-type="bibr" rid="R59">Nakagawa et al., 2016</xref>). Many proteins encoded in ORF1b, are part of the replication complex, thus making the -1 PRF to generate pp1ab a critical translational event for SARS-CoV-2 replication. Frameshifting in coronaviruses is regulated by a highly conserved heptanucleotide slippery sequence (UUUAAAC) and an RNA pseudoknot structure a few nucleotides downstream (<xref ref-type="bibr" rid="R63">Plant and Dinman, 2008</xref>). The current models of PRF suggest that ribosomes stall upon encountering the pseudoknot (<xref ref-type="bibr" rid="R64">Plant et al., 2003</xref>, <xref ref-type="bibr" rid="R41">Korniy et al., 2019</xref>). This event presumably enhances the efficiency of ribosomal frameshifting by forcing the ribosomes to pause on the slippery sequence, which in turn promote the -1 slippage. Once the pseudoknot unwinds and resolves, the ribosomes can continue to translate the alternate ORF.</p>
<p id="P5">Another well-known frameshifting mechanisms in human viruses is employed by retroviruses through a stem-loop structure that regulates the expression of Gag/Gag-Pol transcripts (<xref ref-type="bibr" rid="R34">Jacks et al., 1988</xref>, <xref ref-type="bibr" rid="R82">Wilson et al., 1988</xref>). HIV-1 frameshifting is essential for maintenance of the ratio of Gag and Gag-Pol polyproteins as well as viral infectivity (<xref ref-type="bibr" rid="R73">Shehu-Xhilaga et al., 2001</xref>, <xref ref-type="bibr" rid="R23">Garcia-Miranda et al., 2016</xref>). While frameshifting is thought to be highly inefficient in HIV-1, with only 5-10% of ribosomes continuing into the Pol ORF (<xref ref-type="bibr" rid="R2">Baril et al., 2003</xref>, <xref ref-type="bibr" rid="R18">Dulude et al., 2006</xref>, <xref ref-type="bibr" rid="R34">Jacks et al., 1988</xref>), CoV frameshifting is thought to occur at a much higher efficiency (<xref ref-type="bibr" rid="R33">Irigoyen et al., 2016</xref>, <xref ref-type="bibr" rid="R21">Finkel et al., 2021</xref>, <xref ref-type="bibr" rid="R22">Finkel et al., 2020</xref>). Much of our understanding of viral frameshifting is based on reporter assays in transfected cells. However, to date, a comparison of SARS-CoV-2 and HIV-1 frameshifting efficiencies in infected cells has not been empirically assessed.</p>
<p id="P6">Here, we have conducted in-depth ribosome profiling studies to gain insight into the role of translational regulation in SARS-CoV-2 replication and the resulting host responses. We found that ribosome occupancy on viral mRNAs was temporally regulated and partly dependent on RNA abundance. In addition, ribosomes engaged with novel translation initiation sites (TIS) and other potential regulatory elements on SARS-CoV-2 RNAs. SARS-CoV-2 mRNAs quickly dominated the cellular mRNA pool but were not translated at a higher efficiency than cellular mRNAs overall. In addition, we found accumulation of ribosomes on the SARS-CoV-2 and HIV-1 frameshifting elements, but found that SARS-CoV-2 frameshifting was substantially more efficient than HIV-1. Remarkably, while numerous inflammatory chemokines, cytokines and ISGs were upregulated transcriptionally in SARS-CoV-2-infected Vero E6 cells, we found that many were not efficiently translated. Though we found that mRNAs encoding certain immune defense mediators were also less efficiently translated in primary airway cultures upon SARS-CoV-2 infection, repression of host mRNA translation in this physiologically relevant system was overall more modest. Taken together, our study defines the translational landscape of SARS-CoV-2-infected cells, revealing novel events that may promote viral replication and disarm host immune responses at the level of mRNA translation.</p>
</sec>
<sec id="S2" sec-type="results">
<title>Results</title>
<sec id="S3">
<title>Ribosome profiling reveals key features of SARS-CoV-2 translational program</title>
<p id="P7">To study the relationship between transcriptionally and translationally regulated events at early and late phases of SARS-CoV-2 infection, Vero E6 cells infected at high multiplicity of infection (MOI) were monitored by RNA-seq and ribo-seq during the course of infection for 24 h (<xref ref-type="fig" rid="F1">Fig. 1A</xref>). Viral antigen staining of infected cells revealed that the majority of the cells were infected by 12 hpi (<xref ref-type="supplementary-material" rid="SD1">Fig. S1A</xref>). Triplicate sequencing libraries (RNA-seq and ribo-seq) were generated and the mapping statistics are detailed in <xref ref-type="supplementary-material" rid="SD1">Table S1</xref>, <xref ref-type="supplementary-material" rid="SD1">S2</xref>. The quality of each sample and ribo-seq library was assessed as follows. First, despite the high degree of infection, RNA integrity was unaffected (<xref ref-type="supplementary-material" rid="SD1">Fig. S1B</xref>), suggesting that selection of poly-adenylated mRNAs for RNA-seq is unlikely to introduce a major 3’ bias. Second, the length of distribution of ribo-seq reads that mapped to cellular and viral transcriptomes were within the expected range of ribosome protected fragments (<xref ref-type="supplementary-material" rid="SD1">Fig. S2A</xref>) (<xref ref-type="bibr" rid="R31">Ingolia et al., 2012</xref>, <xref ref-type="bibr" rid="R32">Ingolia et al., 2009</xref>), although we noted that in one replicate experiment read lengths trended to be longer likely due to less extensive nuclease digestion (<xref ref-type="supplementary-material" rid="SD1">Fig. S2A</xref>). Third, irrespective of the differences in the average read-length distribution of independent experiments, the majority of ribo-seq reads mapped to coding sequences (CDS) and 5’ UTRs, with a clear reduction in the fraction of reads mapping to 3’UTRs when compared to RNA-seq experiments done in parallel (<xref ref-type="supplementary-material" rid="SD1">Fig. S2B</xref>). Finally, mapped ribosome-derived reads within the CDSs were enriched in fragments that align to the translated frame for cellular mRNAs (<xref ref-type="supplementary-material" rid="SD1">Fig. S3A, B</xref>). A similar outcome was observed for virally mapping reads except for one replicate where nuclease digestion was incomplete (<xref ref-type="supplementary-material" rid="SD1">Fig. S4</xref>).</p>
<p id="P8">At 2 hpi, only a small fraction of mRNAs was derived from SARS-CoV-2 RNAs (<xref ref-type="fig" rid="F1">Fig. 1B</xref>). At 6 hpi, a dramatic increase in vRNA levels was observed and by 12 hpi, nearly 80% of the total mRNA pool was viral (<xref ref-type="fig" rid="F1">Fig. 1B</xref>). Viral RNAs were present abundantly in the ribosome bound pool as well and by 12 hpi ~50% of the ribosome-protected fragments contained SARS-CoV-2 sequences (<xref ref-type="fig" rid="F1">Fig. 1B</xref>). Plotting of RNA-seq reads on the SARS-CoV-2 genome demonstrated that N-derived sgRNAs were highly abundant throughout infection (<xref ref-type="supplementary-material" rid="SD1">Fig. S5A</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S3</xref>), a finding consistent with previous RNA-seq studies (<xref ref-type="bibr" rid="R39">Kim et al., 2020</xref>, <xref ref-type="bibr" rid="R28">Huang et al., 2020</xref>). Ribosome density on SARS-CoV-2 mRNAs mirrored RNA abundance, with ribosomes enriched primarily on N-coding mRNAs (<xref ref-type="fig" rid="F1">Fig. 1C</xref>, <xref ref-type="supplementary-material" rid="SD1">S5B</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S3</xref>). The translational efficiency of viral mRNAs was not substantially different than the majority of cellular mRNAs with ORF1AB, S and E mRNAs translated at a modestly higher efficiency and the remainder of viral mRNAs translated at a lower efficiency than average, a pattern that did not vary with progression of infection (<xref ref-type="fig" rid="F1">Fig. 1D</xref>). Thus, the high abundance of viral mRNAs, as opposed to a specific regulated mechanism, likely ensures the abundance of viral proteins, a finding consistent with other published studies (<xref ref-type="bibr" rid="R21">Finkel et al., 2021</xref>, <xref ref-type="bibr" rid="R22">Finkel et al., 2020</xref>).</p>
<p id="P9">In two replicate experiments, analysis of ribo-seq derived reads on viral RNAs at 2 hpi revealed the presence of a high occupancy site spanning nucleotides 27371-27457 (<xref ref-type="supplementary-material" rid="SD1">Fig. S6A</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S3</xref>), which accounted for the majority of ribo-seq reads derived from viral RNAs at this time point. Further analysis of reads mapping to this region revealed an average read length distribution smaller than what is expected of ribosome protected fragments (<xref ref-type="supplementary-material" rid="SD1">Fig. S6A</xref>), suggesting that this peak is unlikely to be derived from RPFs. Ribosome occupancy on viral RNAs increased significantly by 6 hpi in all experiments, featuring S and downstream ORFs as the most frequently translated regions (<xref ref-type="fig" rid="F1">Fig. 1C</xref>, <xref ref-type="supplementary-material" rid="SD1">S5B</xref>). Ribosome density noticeably increased also on the ORF1ab by 6hpi, but with lower read counts in ORF1b. Ribosome occupancy across viral RNAs increased further by 12 hpi and remained high during the remainder of infection (<xref ref-type="fig" rid="F1">Fig. 1C</xref>, <xref ref-type="supplementary-material" rid="SD1">S5B</xref>). Ribosome footprints were non-uniform with numerous high and low frequency binding sites observed reproducibly across viral RNAs (<xref ref-type="fig" rid="F1">Fig. 1C</xref>, <xref ref-type="supplementary-material" rid="SD1">S5B</xref>) with expected higher ribosome density within viral translation initiation sites (<xref ref-type="supplementary-material" rid="SD1">Fig. S5B</xref>).</p>
<p id="P10">Similar to other CoVs, SARS-CoV-2 frameshifting is thought to be mediated by a conserved heptanucleotide slippery sequence (UUUAAAC) and a RNA pseudoknot downstream from it spanning nucleotides 13408-13540 (<xref ref-type="supplementary-material" rid="SD1">Fig. S6B</xref>). A notable local increase in ribosome occupancy was observed surrounding the slippery site within the frameshifting element (<xref ref-type="fig" rid="F1">Fig. 1E</xref>, <xref ref-type="supplementary-material" rid="SD1">Fig. S6C</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S3</xref>), suggesting the possibility of steric hindrance by the FSE on translating ribosomes. Frameshifting was also evident in P-site analysis of the mapped reads with a notable shift from frame 0 to frame 2 (-1 frame), before and after the frameshifting site (<xref ref-type="supplementary-material" rid="SD1">Fig. S6C</xref>). Comparison of read density distribution between ORF1a and ORF1b indicated a relatively high efficiency of frameshifting ranging from %50 to %75 throughout the course of infection (<xref ref-type="fig" rid="F1">Fig. 1F</xref>) in line with published reports for SARS-CoV-2 as well as other coronaviruses (<xref ref-type="bibr" rid="R33">Irigoyen et al., 2016</xref>, <xref ref-type="bibr" rid="R15">Dinan et al., 2019</xref>, <xref ref-type="bibr" rid="R22">Finkel et al., 2020</xref>).</p>
<p id="P11">We next tested whether SARS-CoV-2 can utilize alternative translation initiation, which is increasingly recognized as a key post-transcriptional regulatory mechanism (<xref ref-type="bibr" rid="R44">Kwan and Thompson, 2019</xref>, <xref ref-type="bibr" rid="R36">James and Smyth, 2018</xref>). To do so, ribo-seq experiments were performed in the presence of harringtonine, which results in the accumulation of ribosomes at translation initiation sites. In addition to enrichment of ribosomes at the canonical start codons, harringtonine treatment resulted in accumulation of ribosomes at alternative translation initiation sites during the course of infection, albeit at generally lower frequencies. For example, at 6 hpi, an internal noncanonical start codon ‘UUG’ within M ORF was utilized at ~30% of the time, predicted to result in an out-of-frame peptide of 53 amino acids long (<xref ref-type="supplementary-material" rid="SD1">Table S3</xref>, <xref ref-type="supplementary-material" rid="SD1">S4</xref>, <xref ref-type="supplementary-material" rid="SD1">Fig. S7</xref>). An alternative translation initiation codon ‘AGG’ at 21868 nt appeared to be utilized within S at 6, 12 and 24 hpi, which would result in a short 18 amino acid peptide (<xref ref-type="supplementary-material" rid="SD1">Table S3</xref>, <xref ref-type="supplementary-material" rid="SD1">S4</xref>, <xref ref-type="supplementary-material" rid="SD1">Fig. S7</xref>). Finally alternative translation initiation sites were observed within M, resulting in an out-of-frame peptide and a truncated version of M (<xref ref-type="supplementary-material" rid="SD1">Table S3</xref>, <xref ref-type="supplementary-material" rid="SD1">S4</xref>, <xref ref-type="supplementary-material" rid="SD1">Fig. S7</xref>).</p>
</sec>
<sec id="S4">
<title>HIV-1 frameshifting is regulated through a distinct mechanism compared with SARS-CoV-2</title>
<p id="P12">Analogous to SARS-CoV-2, HIV-1 also utilizes -1 ribosomal frameshifting, in this case for generation of the Gag-Pol polyprotein (<xref ref-type="bibr" rid="R34">Jacks et al., 1988</xref>, <xref ref-type="bibr" rid="R82">Wilson et al., 1988</xref>). HIV-1 frameshifting is regulated by a slippery sequence followed by a structured hairpin loop (<xref ref-type="bibr" rid="R58">Mouzakis et al., 2013</xref>, <xref ref-type="bibr" rid="R74">Staple and Butcher, 2005</xref>). To compare the frameshifting efficiency of SARS-CoV-2 to HIV-1, we next performed paired ribo-seq and RNA-seq experiments in HIV-1-infected CD4+ T-cells isolated from two independent donors (<xref ref-type="supplementary-material" rid="SD1">Table S5</xref> and <xref ref-type="supplementary-material" rid="SD1">S6</xref>). Length distribution of ribo-seq derived reads that mapped to cellular and viral mRNAs were within the expected range of ribosome-protected fragments (<xref ref-type="supplementary-material" rid="SD1">Fig. S8A</xref>). In addition, ribo-seq reads that mapped to cellular mRNAs had a 3-nt periodicity in frame with annotated CDSs for varying read lengths (<xref ref-type="supplementary-material" rid="SD1">Fig. S8B, S8C</xref>) and were largely depleted of 3’ UTRs (<xref ref-type="supplementary-material" rid="SD1">Fig. S8D</xref>), suggesting that a large fraction of sequencing reads represent sequences derived from translating ribosomes.</p>
<p id="P13">We found that ribosome occupancy was high within the HIV-1 frameshifting element overlapping the slippery sequence (<xref ref-type="fig" rid="F2">Fig.2A-C</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S7</xref>) but dropped substantially 3’ to it and remained low throughout the Pol ORF (<xref ref-type="fig" rid="F2">Fig. 2A, C</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S7</xref>). Interestingly, another high occupancy site was observed immediately upstream of the slippery sequence within the FSE (<xref ref-type="fig" rid="F2">Fig. 2C</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S7</xref>). This suggests that ribosomes may pause and accumulate within the frameshifting site but only a small fraction of them continue translating into the Pol ORF, a finding that agrees with prior estimates of low (5-10%) HIV-1 frameshifting efficiency (<xref ref-type="bibr" rid="R6">Biswas et al., 2004</xref>, <xref ref-type="bibr" rid="R18">Dulude et al., 2006</xref>, <xref ref-type="bibr" rid="R73">Shehu-Xhilaga et al., 2001</xref>, <xref ref-type="bibr" rid="R2">Baril et al., 2003</xref>, <xref ref-type="bibr" rid="R34">Jacks et al., 1988</xref>). Thus, we conclude that programmed ribosome frameshifting is regulated through distinct mechanisms and possibly structures between HIV-1 and SARS-CoV-2. Interestingly, while the translation efficiency of <italic>Env, Nef</italic> and <italic>Pol</italic> mRNAs were similar to cellular mRNAs, the translation efficiency of the Gag ORF was significantly higher (<xref ref-type="fig" rid="F2">Fig. 2D</xref>), and in part may be ascribed to the unique structural elements present within the 5’UTR of Gag-coding mRNAs (<xref ref-type="bibr" rid="R38">Kharytonchyk et al., 2016</xref>).</p>
</sec>
<sec id="S5">
<title>Ribo-seq in primary HBECs reveal a similar SARS-CoV-2 translational program</title>
<p id="P14">SARS-CoV-2 primarily infects ciliated and type 2 pneumocyte cells in the human lung (<xref ref-type="bibr" rid="R71">Schaefer et al., 2020</xref>). Differentiated primary airway epithelial cells grown at the airliquid interface (ALI) represent one of the most physiologically relevant models to study SARS-CoV-2 infection in culture. To corroborate the above findings from Vero E6 cells, we performed ribo-seq studies in SARS-CoV-2-infected primary human bronchial epithelial cells (HBEC) grown at the air-liquid interface (ALI). Cells inoculated at an MOI of 1 were processed for RNA-seq and ribo-seq at 4, 24, 48, 72 and 96 hpi (<xref ref-type="fig" rid="F3">Fig. 3A</xref>). In contrast to the highly permissive Vero E6 cells, the progression of infection in HBECs was relatively slow and a small percentage of the cells were infected by 4 and 24 hpi (not shown). SARS-CoV-2 spread was visible by 48 hpi and a large fraction of ciliated cells expressing ACE2 were infected by 96 hpi (<xref ref-type="supplementary-material" rid="SD1">Fig. S9A, 9B</xref>). In agreement, the amount of newly synthesized viral RNAs was low at 4 hpi, but by 48 hpi approximately 20% of reads were of viral origin and did not increase further at 72 and 96 hpi (<xref ref-type="fig" rid="F3">Fig. 3B</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S8</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S9</xref>). Of the relatively small number of RNA-seq-derived reads that mapped to the viral RNAs at 4 hpi, the majority were derived from subgenomic viral mRNAs coding for N and to a lesser extent from upstream ORFs including M, ORF6, ORF7 and ORF8 (<xref ref-type="supplementary-material" rid="SD1">Fig. S10</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S10</xref>). Subgenomic viral mRNAs coding for N remained as the predominant species at later time points with notable increases at the expression level of upstream genes (<xref ref-type="supplementary-material" rid="SD1">Fig. S10</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S10</xref>).</p>
<p id="P15">Quality of ribo-seq libraries was assessed as follows. First, as with previous experiments, RNA integrity was high despite widespread infection at 96 hpi (<xref ref-type="supplementary-material" rid="SD1">Fig. S11A</xref>). Second, length distribution of ribo-seq reads mapping to cellular and viral mRNAs matched the size expected from ribosome-protected fragments (<xref ref-type="supplementary-material" rid="SD1">Fig. S11B</xref>). Third, reads mapping to the 3’UTRs were depleted in ribo-seq libraries (<xref ref-type="fig" rid="F3">Fig. 3C</xref>). Fourth, ribo-seq libraries were enriched in fragments that align to the translated frame and had a dominant frame with a 3-nt periodicity across varying read lengths for both cellular and virally mapping reads (<xref ref-type="supplementary-material" rid="SD1">Fig. S12</xref>, <xref ref-type="supplementary-material" rid="SD1">S13</xref>).</p>
<p id="P16">In contrast to Vero E6 cells, viral RNAs constituted only a small fraction of ribo-seq-derived RNAs (<xref ref-type="fig" rid="F3">Fig. 3B</xref>) suggesting a significantly more restrictive translational environment overall for SARS-CoV-2 in ALI cultures. Ribosomes bound by viral RNAs were readily detected at 24, 48, and 72 hpi, but not at 4 hpi, with N and M ORFs being the most frequently translated (<xref ref-type="fig" rid="F3">Fig. 3C</xref>). Overall translation efficiency of SARS-CoV-2 mRNAs was by and large proportional to the abundance of sgRNAs and proceeded in a similar cascade in the primary HBECs as well as in the Vero E6 cells. Due to the relatively low read coverage across ORF1ab, we did not assess frameshifting efficiency in this experimental setting.</p>
</sec>
<sec id="S6">
<title>Inflammatory and innate immune mRNAs are inefficiently translated in SARS-CoV-2 infected cells</title>
<p id="P17">Parallel analysis of ribo-seq and RNA-seq data sets provides a powerful tool to analyze translational level changes in response to SARS-CoV-2 infection. Paired RNA-seq and ribo-seq data obtained from three independent experiments were analyzed for differential gene expression patterns in Vero E6 cells. Principal component analysis (PCA) showed samples separated well based on time post-infection despite a level of variability in particular at the 6 hpi time point (<xref ref-type="supplementary-material" rid="SD1">Fig. S14A-C</xref>).</p>
<p id="P18">Hierarchical consensus clustering of the 1,018 differentially expressed genes (DEGs) (|logFC|&gt;2 and q&lt;0.05) from RNA-seq generated 5 temporally resolved clusters (<xref ref-type="fig" rid="F4">Fig. 4A</xref>, <xref ref-type="supplementary-material" rid="SD1">S15A</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S11</xref>). As early as 2 hpi, we found transcriptional upregulation of transcription factors involved in cell cycle regulation and induction of inflammation (i.e.NR4A3 and EGR3) (<xref ref-type="fig" rid="F4">Fig. 4A</xref>, <xref ref-type="supplementary-material" rid="SD1">S16A</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S11</xref>). Numerous chemokine ligands (CXCL1, CXCL3, CXCL11, cluster 1) as well as IFN-α/β signaling and downstream ISGs significantly increased at 6 and 12 hpi (cluster 3; <xref ref-type="fig" rid="F4">Fig 4A</xref>, <xref ref-type="supplementary-material" rid="SD1">S15A</xref>, <xref ref-type="supplementary-material" rid="SD1">S16A</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S11</xref>).</p>
<p id="P19">Induction of inflammatory and innate immune pathways were confirmed by gene set enrichment analysis (GSEA) of genes at each time point (<xref ref-type="fig" rid="F4">Fig. 4B</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S11</xref>). Another cluster (cluster 2) of upregulated genes were composed of genes involved in mRNA processing and mRNA translation (<xref ref-type="fig" rid="F4">Fig. 4A, 4B</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S11</xref>). Though numerous genes in clusters 4 and 5 were downregulated in all replicate experiments, we did not observe the specific enrichment of a pathway in this set of DEGs.</p>
<p id="P20">Remarkably, the majority of these transcript level changes were not apparent in Ribo-seq data (<xref ref-type="fig" rid="F4">Fig. 4C, 4D</xref>, <xref ref-type="supplementary-material" rid="SD1">S15B</xref>, <xref ref-type="supplementary-material" rid="SD1">S16B</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S11</xref>). Only 234 genes were found to be differentially regulated in response to SARS-CoV-2 infection forming 10 temporally-resolved clusters (<xref ref-type="fig" rid="F4">Fig. 4C</xref>, <xref ref-type="supplementary-material" rid="SD1">S15B</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S11</xref>). Many of these clusters were smaller in size and the degree of differential expression varied in clusters 7-10 between replicate experiments (<xref ref-type="fig" rid="F4">Fig. 4C</xref>, <xref ref-type="supplementary-material" rid="SD1">S15B</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S11</xref>). Notwithstanding, cluster 2 (ribo-seq), which was enriched for type-I IFN response pathway was substantially smaller in size and consisted of only a few ISGs (i.e. IFIT1, IFIT2, IFIT3 and CXCL10) (<xref ref-type="fig" rid="F4">Fig. 4C</xref>, <xref ref-type="supplementary-material" rid="SD1">S15B</xref>, <xref ref-type="supplementary-material" rid="SD1">S16B</xref> <xref ref-type="supplementary-material" rid="SD1">Table S11</xref>). In contrast, we found that another innate immune modulator, IL11, was significantly upregulated translationally but not transcriptionally at 2hpi (<xref ref-type="supplementary-material" rid="SD1">Fig. S16B</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S11</xref>). Clusters 3 and 4 consisted of genes that were downregulated significantly but were not significantly enriched for a particular pathway (<xref ref-type="supplementary-material" rid="SD1">Table S11</xref>). Together, these findings suggest that immune response genes are translationally repressed, and their expression significantly delayed in infected cells.</p>
<p id="P21">Many of these findings held consistent for the RNA-seq and ribo-seq experiments performed on Vero E6 cells infected at a low MOI (<xref ref-type="supplementary-material" rid="SD1">Table S12</xref>, <xref ref-type="supplementary-material" rid="SD1">S13</xref>). For example, transcription factors ATF3 and EGR1, key regulators of inflammatory responses, were upregulated at 24 hpi alongside with numerous chemokine ligands (i.e. CXCL1, CXCL8, CXCL10) and interleukin 6 (<xref ref-type="supplementary-material" rid="SD1">Fig. S17A</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S14</xref>). We also noted the upregulation of numerous ISGs (i.e. IFIT1, IFIT2, IFIT3) as well as IFN-lambda at 24 hpi (<xref ref-type="supplementary-material" rid="SD1">Fig. S17A</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S14</xref>). The 48 hpi timepoint was marked by upregulation of genes involved in cell cycle regulation and apoptosis (i.e. FOS, NR4A3), as well as inflammatory cytokines such as IL-31 and ISGs including OASL (<xref ref-type="supplementary-material" rid="SD1">Fig. S17B</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S14</xref>). In line with our above observations, the great majority of the transcriptionally upregulated genes were not translationally upregulated at 24 hpi (<xref ref-type="supplementary-material" rid="SD1">Fig. S17B</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S14</xref>) and 48 hpi (<xref ref-type="supplementary-material" rid="SD1">Fig.S17B</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S14</xref>). Interleukins IL11 and IL1A stood out as immune-related genes that were translationally upregulated at 24 and 48 hpi, respectively (<xref ref-type="supplementary-material" rid="SD1">Fig. S17B</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S14</xref>).</p>
<p id="P22">Paired RNA-seq and ribo-seq data obtained from four independent infections of HBECs grown at ALI (from two independent donors) were analyzed for differential gene expression similarly. Principal component analysis (PCA) showed samples separated well based on time post-infection as well as donor samples (<xref ref-type="supplementary-material" rid="SD1">Fig. S18A</xref>). Furthermore, the level of gene level biological variability was within a reasonable range for both RNA-seq and ribo-seq libraries (<xref ref-type="supplementary-material" rid="SD1">Fig. S18B, C</xref>). SARS-CoV-2 infection induced differential expression of 2727 and 1208 genes in RNA-seq and ribo-seq experiments, respectively (<xref ref-type="supplementary-material" rid="SD1">Table S15</xref>, <xref ref-type="supplementary-material" rid="SD1">S16</xref>). As expected from the low level of infection at 4 hpi, relatively few genes were differentially regulated at this time point for both RNA-seq and ribo-seq data sets (<xref ref-type="supplementary-material" rid="SD1">Table S15</xref>, <xref ref-type="supplementary-material" rid="SD1">S16</xref>). Transcriptionally upregulated genes formed six temporally resolved clusters (<xref ref-type="fig" rid="F5">Fig. 5A</xref>, <xref ref-type="supplementary-material" rid="SD1">S19A</xref>, <xref ref-type="supplementary-material" rid="SD1">S20A</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S15</xref>). Cluster 2, which contained the largest number of upregulated DEGs, was significantly enriched in genes in the type I/III IFN pathway and inflammatory responses (<xref ref-type="fig" rid="F5">Fig. 5B</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S15</xref>). Clusters 4 and 5 were composed of genes that were downregulated at later stages of infection (<xref ref-type="fig" rid="F5">Fig. 5A</xref>, <xref ref-type="supplementary-material" rid="SD1">S19A</xref>, <xref ref-type="supplementary-material" rid="SD1">S20A</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S15</xref>). GSEA revealed that many of these genes are involved in cilium organization and movement (<xref ref-type="fig" rid="F5">Fig. 5B</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S15</xref>), demonstrating the impact of SARS-CoV-2-induced remodeling and/or killing of the ciliated cells in the airway cultures. In contrast to Vero E6 cells, the majority of these patterns were maintained in ribo-seq experiments. The 1208 DEGs derived from the ribo-seq experiments formed 5 clusters, with clusters 1-3 consisting of translationally upregulated genes (<xref ref-type="fig" rid="F5">Fig. 5C</xref>, <xref ref-type="supplementary-material" rid="SD1">S19B</xref>, <xref ref-type="supplementary-material" rid="SD1">20B</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S16</xref>). While clusters 1 and 3 were not enriched in genes in a specific pathway, we found that Cluster 2 was significantly enriched in genes in the IFN and inflammatory response pathways (<xref ref-type="fig" rid="F5">Fig. 5D</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S16</xref>). Similar to RNA-seq data, GSEA of downregulated DEGs in cluster 5 revealed enrichment of genes involved in cilium organization and motility (<xref ref-type="fig" rid="F5">Fig. 5D</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S16</xref>).</p>
</sec>
<sec id="S7">
<title>Comparison of SARS-CoV-2 and host mRNA translation efficiencies</title>
<p id="P23">We next compared the translational efficiency of cellular host response genes in Vero E6 and primary HBEC cultures. In Vero E6 cells the translation efficiency of various immune modulatory genes was substantially lower than other cellular mRNAs, most evident at 12 and 24 hpi which marks the accumulation of viral proteins (<xref ref-type="fig" rid="F6">Fig. 6A-D</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S17</xref>). In contrast, in HBEC-ALI cultures, the translation efficiency of mRNAs encoding ISGs and inflammatory genes did not appear to be significantly lower than other cellular mRNAs (<xref ref-type="fig" rid="F6">Fig. 6E-H</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S18</xref>). Notable exceptions included CXCL9 and IFN-B, which were substantially upregulated at 48hpi at the transcript level but had lower translation efficiencies (<xref ref-type="fig" rid="F6">Fig. 6F</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S18</xref>).</p>
<p id="P24">Numerous viral proteins have been implied in modulation of type-I IFN responses and we next tested the direct impact of some of these factors in suppression of ISG expression. To this end, cells transfected with Nsp1, Nsp7, ORF3a and ORF6 expression constructs were stimulated with IFN-α and induction of ISGs assessed by immunoblotting and Q-RT-PCR. We found that Nsp1 overexpression significantly reduced IFN-α-mediated phosphorylation of STAT1 (<xref ref-type="fig" rid="F7">Fig. 7A</xref>), whereas other viral proteins had no impact on STAT1 levels or phosphorylation. Nsp1-mediated suppression of STAT1 phosphorylation was accompanied by a significant reduction of ISG upregulation at both protein and RNA level (<xref ref-type="fig" rid="F7">Fig. 7A-C</xref>). While ORF3a and ORF6 did not affect STAT1 phosphorylation, they both reduced steady state ISG expression (<xref ref-type="fig" rid="F7">Fig. 7A</xref>), yet the impact on ISG protein levels was relatively modest (<xref ref-type="fig" rid="F7">Fig. 7B</xref>). These findings suggested that the observed translational repression of innate immune modulators in SARS-CoV-2-infected cells is likely due to the actions of multiple viral proteins and possibly due virus-induced changes and stress in heavily infected cells.</p>
</sec>
</sec>
<sec id="S8" sec-type="discussion">
<title>Discussion</title>
<p id="P25">Here we utilized ribosome profiling (ribo-seq) coupled with RNA-seq to study the translational events that regulate viral gene expression and host responses over the course of SARS-CoV-2 infection. SARS-CoV-2 replicates rapidly, with viral RNAs constituting the great majority of the total mRNA pool soon after infection. Our data show that viral mRNA abundance is the main determinant of viral protein expression and SARS-CoV-2 mRNAs sequester ribosomes from the translating pool by competition, simply outnumbering the host counterparts. Notwithstanding certain viral mRNAs (i.e. those encoding S, E and ORF1ab) were translated modestly more efficiently than others. While the overall conclusions are similar, another study found that ORF1ab was less efficiently translated compared with other viral mRNAs (<xref ref-type="bibr" rid="R22">Finkel et al., 2020</xref>), which we ascribe to possible differences in read depth (with our study having substantially higher read depth within ORF1ab), RNA-seq approaches and infection conditions and cell lines.</p>
<p id="P26">We observed that, in contrast to HIV-1, SARS-CoV-2 RNA employs a highly efficient frameshifting strategy to facilitate virus replication. Ribosomal frameshifting requires a heptanucleotide slippery sequence and a RNA pseudoknot, generally a H-type, positioned six to eight nucleotides downstream (<xref ref-type="bibr" rid="R24">Giedroc and Cornish, 2009</xref>). Multiple models for ribosomal frameshifting posit that the ribosome pauses at the slippery sequence upon encountering the pseudoknot, which is resistant to unwinding (<xref ref-type="bibr" rid="R19">Farabaugh, 1996</xref>, <xref ref-type="bibr" rid="R16">Dinman, 2012</xref>). While paused, ribosomes either stay in-frame or slip - 1 nt before resuming translation. A corollary of this notion is that the stimulatory structure, in turn, enhances frameshifting efficiency by promoting ribosomal pausing. In line with this, we observed a local increase in ribosome density overlapping the slippery sequence for both SARS-CoV-2 and HIV-1 (<xref ref-type="fig" rid="F1">Fig. 1E</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S3</xref>), which is also supported by recent structural studies of the ribosome-bound SARS-CoV-2 frameshifting element (<xref ref-type="bibr" rid="R4">Bhatt et al., 2021</xref>). Notably, in the case of HIV-1 the increase density of ribosomes extended 100 nucleotides upstream of the frameshifting site, suggesting an alternative frameshifting structure that includes upstream sequences or steric hindrance imposed by the pseudoknot structure. Ribosome density downstream of the frameshifting site within the SARS-CoV-2 ORF1b was high with ribosomes continuing into the ORF1b frame &gt;50% of the time, suggesting the comparably high efficiency of SARS-CoV-2 frameshifting relative to HIV-1 in spite of ribosomal pausing.</p>
<p id="P27">We hypothesize that both sequence-specific and structural features contribute to SARS-CoV-2 frameshifting efficiency. It is thought that HIV-1 has a particularly slippery sequence (UUUUUUA) as compared to SARS-CoV-2 (UUUAAAC), which may underlie this difference (<xref ref-type="bibr" rid="R24">Giedroc and Cornish, 2009</xref>). In addition, structures downstream of the slippery sequence may have an impact (<xref ref-type="bibr" rid="R63">Plant and Dinman, 2008</xref>). For example, the HIV-1 frameshifting element is predicted to have a simpler pseudoknot (<xref ref-type="bibr" rid="R10">Chang et al., 1999</xref>, <xref ref-type="bibr" rid="R61">Parkin et al., 1992</xref>, <xref ref-type="bibr" rid="R8">Brierley and Dos Ramos, 2006</xref>, <xref ref-type="bibr" rid="R29">Huang et al., 2014</xref>) or hairpin loop structure (<xref ref-type="bibr" rid="R58">Mouzakis et al., 2013</xref>, <xref ref-type="bibr" rid="R74">Staple and Butcher, 2005</xref>). In particular, previous studies suggest that frameshifting efficiency positively correlates with the mechanical stability and thermodynamic stability of the pseudoknot and stem loop, respectively (<xref ref-type="bibr" rid="R25">Hansen et al., 2007</xref>, <xref ref-type="bibr" rid="R12">Chen et al., 2009</xref>, <xref ref-type="bibr" rid="R5">Bidou et al., 1997</xref>). In addition, host proteins can also affect frameshifting. Of note, an interferon-stimulated gene (ISG) product, known as C19orf66 (Shiftless), has recently been demonstrated to impair HIV-1 replication through inhibition of HIV-1 programmed frameshifting (<xref ref-type="bibr" rid="R78">Wang et al., 2019</xref>). Altogether, our data suggest that SARS-CoV-2 and HIV-1 frameshifting occurs through distinct mechanisms. It remains to be determined how distinct elements within the frameshifting site affect and whether other viral or cellular proteins are involved in modulating the frameshifting efficiencies of these viruses. In addition to frameshifting, we demonstrate that alternative, non-canonical translational start sites internal to several viral genes such as S, E and M, can result in truncated isoforms or short peptides (<xref ref-type="supplementary-material" rid="SD1">Table S4</xref>). Relevance of such findings to SARS-CoV-2 pathogenesis will depend on the development of reverse-genetically modified SARS-CoV-2 strains.</p>
<p id="P28">Our study provides an in depth picture of how host cell responses to SARS-CoV-2 are regulated at a post-transcriptional level. For example, in the highly permissive Vero E6 cells, we observed upregulation of proinflammatory chemokines as early as 6 hpi followed by a more delayed induction of ISGs, a finding in line with previous observations in immortalized lung cell lines (<xref ref-type="bibr" rid="R7">Blanco-Melo et al., 2020</xref>). However, the increase in transcript abundance did not correlate with higher levels of translation and the great majority of the innate immune response genes appeared to be translated at a low efficiency (<xref ref-type="fig" rid="F6">Fig. 6A-D</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S17</xref>). Apart from this specific effect on, we did not observe a global shutdown of host mRNA translation and most cellular mRNAs were translated proportional to their mRNA abundance.</p>
<p id="P29">Translational repression of innate immune genes was less apparent in the complex setting of primary HBECs grown at ALI though several chemokine ligands and IFN-B trended to be less efficiently translated (<xref ref-type="fig" rid="F6">Fig. 6E-H</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S18</xref>). The potential factors that underlie the difference between Vero E6 cells and HBEC-ALI cultures are many-fold. First, Vero E6 cells, as well as other cell line models broadly used in the field (i.e. ACE2 overexpressing cell lines), are unusually permissive to infection allowing quick accumulation of viral proteins with established effects on host mRNA degradation and translation. Second, majority of published models for SARS-CoV-2 infection have utilized cancer-derived cell lines (i.e. Calu-3, A549, Caco-2, Huh7) that often lack kay arms of innate immunity and/or overexpress ACE2, which also enhances rapid SARS-CoV-2 replication. In fact, it is apparent in the HBEC-ALI model that viral translation, and therefore accumulation of viral proteins, may be overall more restricted compared with the highly permissive Vero E6 cells. Third, HBEC-ALI model is composed of other cell types (i.e. basal, club and BC/club cells) that do not express ACE2, and hence are not as efficiently infected by SARS-CoV-2, though there is some evidence that cell tropism can expand to these cells at later stages of SARS-CoV-2 replication (<xref ref-type="bibr" rid="R67">Ravindra et al., 2021</xref>). Thus, it is possible that the observed upregulation of inflammatory and innate immune genes takes place in the uninfected bystander cells that do not express viral proteins, a finding consistent with recent scRNA-seq studies (<xref ref-type="bibr" rid="R67">Ravindra et al., 2021</xref>). Finally, it is possible that the observed translational repression of innate immune factors may be cell type specific and dependent on high degree of infection. For example, our recent RNA-seq and proteomics studies in the H522 lung adenocarcinoma cells, where SARS-CoV-2 infection progresses slowly, did not reveal a major translational repression of mRNAs encoding host defense factors (<xref ref-type="bibr" rid="R65">Puray-Chavez et al., 2021</xref>).</p>
<p id="P30">The apparent low translation efficiency of host response mRNAs in Vero E6 cells may be mediated by the SARS-CoV-2 protein NSP1, which associates tightly with the 40S ribosomal subunit as well as non-translating 80S ribosomes to prevent binding of capped mRNA and thus inhibit the formation of the translation initiation complex (<xref ref-type="bibr" rid="R72">Schubert et al., 2020</xref>, <xref ref-type="bibr" rid="R1">Banerjee et al., 2020</xref>, <xref ref-type="bibr" rid="R76">Thoms et al., 2020</xref>, <xref ref-type="bibr" rid="R46">Lapointe et al., 2021</xref>), much like its SARS-CoV counterpart (<xref ref-type="bibr" rid="R60">Narayanan et al., 2015</xref>). In addition, there is increasing evidence that ectopic expression of NSP1 can alter host mRNA translation (<xref ref-type="bibr" rid="R66">Rao et al., 2021</xref>). Given the high abundance of ribosomes in the cell, whether physiologically relevant concentrations of NSP1 is sufficient to induce a global block in mRNA translation remains unknown. For example, even in cells overexpressing NSP1, we did not observe a major translational block to ISG induction (<xref ref-type="fig" rid="F7">Fig. 7</xref>). Rather, NSP1 expression blocked STAT1 phosphorylation and subsequently reduced transcriptional induction of ISGs. Thus the observed translational repression of ISGs in the heavily-infected Vero E6 cells is likely due to a combination of viral mRNAs dominating the cellular mRNA pool, other viral proteins such as NSP1 and possibly due to reduced translation initiation due to cellular stress induced by SARS-CoV-2. Finally, we cannot rule out the possibility that the translational suppression of innate immune genes is also contributed by the host’s attempt to curb viral replication, including members of the IFIT family with known functions in translation inhibition (<xref ref-type="bibr" rid="R30">Hyde and Diamond, 2015</xref>, <xref ref-type="bibr" rid="R20">Fensterl and Sen, 2015</xref>, <xref ref-type="bibr" rid="R68">Reynaud et al., 2015</xref>, <xref ref-type="bibr" rid="R13">Daffis et al., 2010</xref>, <xref ref-type="bibr" rid="R14">Diamond and Farzan, 2013</xref>). Future studies are warranted to empirically test these possibilities and define the mechanism of apparent innate immune suppression.</p>
<p id="P31">While COVID-19 pathogenesis is in part due to virus-induced destruction of infected cells, elevated production of inflammatory mediators and the virus-induced immunopathology are thought to play a big role in SARS-CoV-2-induced lung injury (<xref ref-type="bibr" rid="R11">Channappanavar and Perlman, 2017</xref>, <xref ref-type="bibr" rid="R62">Perlman and Dandekar, 2005</xref>). Our findings suggest that immune responses in actively infected cells may be dampened or delayed for SARS-CoV-2 to efficiently replicate and release viral progeny. As such, it is possible that the elevated levels of inflammatory mediators <italic>in vivo</italic> is due to by-stander cells or infection of immune cell subsets, such as monocytes and macrophages, that are less permissive to SARS-CoV-2 but can sense and respond to infection by secretion of immune modulatory molecules (<xref ref-type="bibr" rid="R35">Jafarzadeh et al., 2020</xref>).</p>
<p id="P32">Taken together, we provide novel insight into and a rich resource on how translational regulation shapes SARS-CoV-2 replication and host responses. Our finding that induction of inflammatory and innate immune responses can be limited at the level of mRNA translation provides a paradigm shifting mechanism of how SARS-CoV-2 can encounter immune responses. Modulation of viral RNA structures and proteins that regulate mRNA translation will undoubtedly provide a unique avenue for therapeutic development. Together, our study provides an in-depth picture of translationally regulated events in SARS-CoV-2 replication and reveal that impairment of host mRNA translation may allow SARS-CoV-2 to evade host immunity.</p>
</sec>
<sec sec-type="materials | methods" specific-use="web-only" id="S9">
<title>Materials and methods</title>
<sec id="S10">
<title>Chemicals and reagents</title>
<p id="P33">Standard laboratory chemicals were obtained from reputable suppliers such as Sigma-Aldrich. Cycloheximide (CHX) was obtained from Sigma, dissolved in ethanol and stored at -20°C. Harringtonine (HT) was purchased from LKT Laboratories, Inc., resuspended in DMSO and stored in aliquots of 2 mg/mL at -20°C.</p>
</sec>
<sec id="S11">
<title>Plasmids and viruses</title>
<p id="P34">A proviral plasmid encoding the full length HIV-1 genome was obtained from NIH AIDS Reagents. HIV-1 stocks were generated by transfection of Human embryonic kidney cell line, HEK293T, with proviral plasmids and collection of cell culture supernatants two days after. Viruses were treated by DNase to avoid plasmid carryover and concentrated by Lenti-X concentrator. HIV-1 stocks were titered on TZM-bl cells by conventional methods. CD4<sup>+</sup> T-cells activated for 4-5 days were used for HIV-1 infections. SARS-CoV-2 strain 2019-nCoV/USA-WA1/2020 was obtained from Natalie Thornburg at the Centers for Disease Control and Prevention (CDC), propagated in Vero CCL-81 cells and titrated on Vero E6 cells by plaque-forming assays. SARS-CoV-2 Neon-green reporter virus has been explained before (<xref ref-type="bibr" rid="R84">Xie et al., 2020</xref>) and was propagated and titered similarly. Mammalian expression plasmids encoding SARS-CoV-2 genes (NSP1, NSP7, ORF3a, ORF6) were obtained from BEI resources and propagated as recommended.</p>
</sec>
<sec id="S12">
<title>Cells and infections</title>
<p id="P35">HEK293T and TZM-bl cells were obtained from ATCC and NIH AIDS Reagent Program respectively and were maintained in Dulbecco’s Modified Eagle’s Medium (DMEM) (high glucose), supplemented with 10% fetal bovine serum (FBS) in a humidified incubator at 37°C with 5% CO<sub>2</sub>. For isolation of primary CD4<sup>+</sup> T-cells, buffy coats (from anonymous healthy blood donors from Mississippi Blood Center) were separated by Ficoll and CD4<sup>+</sup> T-cells purified using RosetteSep Human CD4<sup>+</sup> T-cell enrichment kit (STEMCELL Technologies). CD4<sup>+</sup> T-cells cells were maintained in Roswell Park Memorial Institute 1640 medium (RPMI) supplemented with 10% heat-inactivated FBS and L-glutamine. Activation of CD4<sup>+</sup> T cells was achieved by addition of 25 U/ml of interleukin-2 (IL-2) and CD4<sup>+</sup> T-cell activation Dynabeads (Life Technologies). CD4<sup>+</sup> T-cells activated for 4-5 days were used for HIV-1 infections. Vero CCL-81 and Vero E6 were cultured in DMEM supplemented with 10% FBS and 10 mM HEPES pH 7.4. For SARS-CoV-2 infections, Vero E6 cells were incubated with SARS-CoV-2 inoculum in DMEM-supplemented with 2% FBS for an hour in a humidified incubator at 37°C, after which the initial inoculum was removed and replaced by cell culture media.</p>
<p id="P36">Primary human bronchial epithelial cells (HBECs) grown at air-liquid interface (ALI). Human airway epithelial cells were isolated from surgical excess of tracheobronchial segments of lungs donated for transplantation as previously described and were exempt from regulation by US Department of Health and Human Services regulation 45 Code of Federal Regulations Part 46 (<xref ref-type="bibr" rid="R26">Horani et al., 2012</xref>). Tracheobronchial cells were expanded in culture, seeded on supported membranes (Transwell; Corning, Inc.), and differentiated using ALI conditions as detailed before (<xref ref-type="bibr" rid="R85">You et al., 2002</xref>, <xref ref-type="bibr" rid="R27">Horani et al., 2018</xref>).</p>
</sec>
<sec id="S13">
<title>Immunofluorescence</title>
<p id="P37">Infected Vero E6 cells and HBECs were fixed with 4% paraformaldehyde for 20 min at room temperature, followed by permeabilization using 0.5% Tween-20 in PBS for 10 min. Cells were blocked with 1% bovine serum albumin (BSA) and 10% FBS in 0.1% Tween-20 PBS (PBST) for 1 h prior to staining with a rabbit polyclonal anti SARS-CoV-2 nucleocapsid antibody (Sino Biological Inc. catalog # 40588-T62) diluted 1:500 and incubated overnight at 4°C. The following day, cells were stained with an Alexa Fluor 488-conjugated goat anti-rabbit secondary antibody (Invitrogen) at 1:1000 dilution, counter-stained with DAPI and imaged by immunofluorescence microscopy.</p>
</sec>
<sec id="S14">
<title>RNA in situ hybridization</title>
<p id="P38">Primary-culture human airway epithelial cells were fully differentiated at air-liquid interface on supported plastic membranes (Transwell, Corning). Cells were fixed by immersion of the Transwell membrane in methanol:acetone (50:50% volume) at -20 °C for 20 min followed by 4% paraformaldehyde at room temperature for 15 min. Cells were washed three times with phosphate buffered saline (PBS) and stored at 4 °C. Prior to probing for vRNA, membranes containing cells were cut from plastic supports, divided into 4 pieces, and placed in a fresh 48-well plate. RNA detection was performed using the manufacturer protocol for RNAscope fluorescent in situ hybridization (RNAscope Multiplex Fluorescent v2 Assay kit, Advanced Cell Diagnostics). Briefly, cells on membranes were treated with 3% hydrogen peroxide for 10 min at room temperature, washed with distilled water, then treated with protease III solution, diluted 1:15 in PBS, for 10 min in a humidified hybridization oven at 40□°C. The cells were then washed with PBS and incubated for 2 hr at 40□°C with manufacturer designed anti-sense probes specific for SARS-CoV-2 positive strand S gene encoding the spike protein (RNAscope Probe-V-nCoV2019-S, cat# 848561) or ORF1ab (RNAscope Probe-V-nCoV2019-orf1ab-O2-sense-C2 cat # 854851-C2). The probes were visualized according to the manufacturers’ instructions by incubation with RNAscope amplifiers, horseradish peroxidase, and fluorescent label (Opal fluorophores, Perkin-Elmer). Membranes were mounted on glass slides using anti-fade medium containing DAPI (Fluoroshield, Sigma-Aldrich). Images were obtained using a 5000B Leica microscope equipped with a charge-coupled device camera (Retiga 200R) interfaced with QCapture Pro software (Q Imaging).</p>
</sec>
<sec id="S15">
<title>Ribosome profiling</title>
<p id="P39">Ribosome profiling (Ribo-seq) was performed as described before with the following modifications (<xref ref-type="bibr" rid="R32">Ingolia et al., 2009</xref>, <xref ref-type="bibr" rid="R31">Ingolia et al., 2012</xref>). Mock- and HIV-1- or SARS-CoV-2-infected cells were treated with complete cell culture media supplemented with 0.1 mg/mL CHX for 1 min at room temperature followed by one round of wash in ice-cold PBS supplemented with 0.1 mg/mL CHX. Cells were lysed in 1X mammalian polysome lysis buffer (20 mM Tris·HCl (pH 7.4), 150 mM NaCl, 5 mM MgCl<sub>2</sub>, 1% Triton X-100, 0.1% NP-40, 1 mM DTT, 10 units of DNase I, with 0.1 mg/mL CHX). The cells were then triturated by repeated pipetting and incubated with lysis buffer for at least 20 min to ensure virus inactivation. Lysates were centrifuged for 10 min at ≥20,000 g at 4°C for clarification. The supernatants were split into multiple aliquots, with SDS added to one aliquot to a final concentration of 1% for downstream RNA-seq sample preparation, and flash frozen in a 70% ethanol/dry ice bath or directly placed at - 80°C. RNA extracted from lysates were subjected to Bioanalyzer RNA-Nano analysis. RNA integrity number (RIN) of 8 and above (max RIN = 10) is considered “intact RNA”. Lysates were treated with RNase I (5U/OD<sub>260</sub>) and ribosome-protected fragments were isolated via centrifugation through Microspin S-400 HR columns (GE Healthcare) and purified using the RNA Clean and Concentrator kit (Zymo Research). Recovered ribosome-bound fragments (RBFs) are then subjected to rRNA depletion using RiboZero beads from the TruSeq Stranded Total RNA Library Prep Gold kit (Illumina) and purified using Zymo RNA Clean and Concentrator kit. Fragments were then end-labeled with γ-<sup>32</sup>P-ATP using T4 polynucleotide kinase (NEB), separated on 15% TBE-Urea gels and visualized by autoradiography. RNA fragments of ~30 nt were excised from the gels and purified as detailed before in 400 μL of 0.4 M NaCl supplemented with 4 μL SUPERaseIN. 3’ and 5’ adapters were sequentially ligated as in a previously described protocol (<xref ref-type="bibr" rid="R43">Kutluay et al., 2014</xref>, <xref ref-type="bibr" rid="R42">Kutluay and Bieniasz, 2016</xref>), reverse transcribed and PCR amplified. We acknowledge that our ligation-based library generation protocol may introduce biases towards inserts containing distinct nucleotides at the 5’ and 3’ end. Indeed, we found a modest preference towards Us and Cs in the first position and Gs and Cs in the last position of inserts. Libraries were then sequenced on HiSeq-2000 or NextSeq 500 platforms (Illumina) at the Genome Technology Access Center or the Edison Family Center for Genome Sciences &amp; Systems Biology, respectively, at Washington University School of Medicine. All ribo-seq and RNA-seq data were deposited on GEO database under GSE158930.</p>
</sec>
<sec id="S16">
<title>RNA-seq</title>
<p id="P40">An aliquot of cell lysates harvested from ribosome profiling (Ribo-seq) experiments above was processed in parallel for RNA-seq using TruSeq Stranded mRNA library prep (Illumina) following extraction using Zymo RNA-Clean and Concentrator (5) kit. RNA-seq libraries were constructed using TruSeq RNA single-index adapters and deep sequenced as above at Washington University in St. Louis.</p>
</sec>
<sec id="S17">
<title>Data analysis</title>
<p id="P41">All of the data analysis pipelines used in this study are deposited to GitHub under kutluaylab. Below we detail the salient steps of data analyses:</p>
</sec>
<sec id="S18">
<title>Mapping</title>
<p id="P42">Generated RNA-seq and Ribo-seq data were analyzed by publicly available software and custom scripts. In brief, for Ribo-seq, reads were separated based on barcodes and the adapters trimmed using BBDuk (<ext-link ext-link-type="uri" xlink:href="http://jgi.doe.gov/data-and-tools/bb-tools/">http://jgi.doe.gov/data-and-tools/bb-tools/</ext-link>) and FastX Toolkit (<ext-link ext-link-type="uri" xlink:href="http://hannonlab.cshl.edu/fastx_toolkit/">http://hannonlab.cshl.edu/fastx_toolkit/</ext-link>). The resulting reads were mapped to the viral genome/transcriptome using the Bowtie aligner (<xref ref-type="bibr" rid="R45">Langmead et al., 2009</xref>) (mapping criteria -v 1, -m 10), and to the African green monkey (AGM) (<italic>Chlorocebus sabaeus</italic>) or human genomes (hg19) in STAR (<xref ref-type="bibr" rid="R17">Dobin et al., 2013</xref>) (mapping criteria FilterMismatchNoverLmax 0.04). For ribo-seq reads that map to the SARS-CoV-2 genome, reads were additionally collapsed to minimize PCR overamplification artifacts. For AGM/human alignments, reads were first mapped to rRNA to remove any rRNA-derived reads not completely removed by depletion kits and to the SARS-CoV-2 genome to remove virally derived reads. The remaining reads were then first mapped to the SARS-CoV-2 genome (to remove viral reads) and then to the AGM/human genomes. RNA-seq reads were similarly mapped using STAR, although the rRNA alignment step was omitted. For AGM/human alignments, mapped reads were annotated using the featureCounts package and GTF files freely available from NCBI and Ensembl.</p>
</sec>
<sec id="S19">
<title>Statistical Analysis</title>
<p id="P43">Differential gene expression analysis was carried out using the edgeR package (<xref ref-type="bibr" rid="R69">Robinson et al., 2010</xref>). Considering that virally derived sequences quickly dominated the host mRNA pool, for differential gene expression of host mRNAs, library sizes were normalized relative to reads that map only to host mRNAs. Efforts in this area focused on determining upregulated genes using individual Ribo-seq and RNA-seq experiments, as well as the analysis of log<sub>2</sub>-fold change differences between Ribo-seq and RNA-seq to discover translationally regulated genes. These same files and packages were also used to generate quality control plots and graphics highlighting differentially expressed genes. The calculation of translational efficiency involved normalizing counts to account for library size in edgeR to generate log<sub>2</sub> counts-per-million (log<sub>2</sub>CPM) estimates for each gene in Ribo-seq and RNA-seq, and subtracting log<sub>2</sub>CPM RNA-seq from log<sub>2</sub>CPM Ribo-seq to provide an estimate of the difference in expression level between Ribo-seq and RNA-seq for a given gene.</p>
<p id="P44">Downstream analysis of sets of differential genes involved the use of goseq (<xref ref-type="bibr" rid="R86">Young et al., 2010</xref>) and KEGGREST R packages (<xref ref-type="bibr" rid="R75">Tenenbaum, 2020</xref>). Annotations of 5’UTRs, CDSs and 3’UTRs were retrieved and repetitive low-complexity elements were removed. The R package riboWaltz (<xref ref-type="bibr" rid="R47">Lauria et al., 2018</xref>) and the Ribo-TISH package (<xref ref-type="bibr" rid="R88">Zhang et al., 2017</xref>) were utilized to determine the location of ribosomal P-sites with respect to the 5’ and 3’ end of reads, as well as illustrating triplet periodicity and determining the percentage of reads within each frame in CDS and UTR. Finally, the metagene R package (<xref ref-type="bibr" rid="R3">Beauparlant, 2020</xref>) was applied to generate an aggregate analysis of ribosomal density downstream of start codons and upstream of stop codons in the corresponding genome.</p>
<p id="P45">Alternative TIS sites in both host and viral reads were found using the Ribo-TISH package (<xref ref-type="bibr" rid="R88">Zhang et al., 2017</xref>). For viral TIS, analysis was carried out in the ‘predict’ mode comparing samples mock-treated or treated with harringtonine at each timepoint (with replicates). This was replicated for host analysis, although with the additional step of analysis in the ‘diff’ mode to predict TIS differentially regulated between infected and uninfected cells.</p>
</sec>
<sec id="S20">
<title>Cluster analysis</title>
<p id="P46">RNA-seq and ribo-seq logCPM values were each converted to per-gene z-scores. Consensus clustering was then performed with the R ConsensusClusterPlus package (<xref ref-type="bibr" rid="R81">Wilkerson and Hayes, 2010</xref>). The non-defaults settings used were: reps=50, innerLinkage-“complete”, and finalLinkage=“ward.D2”. The optimal number of clusters was chosen by manual inspection of clustering quality for consensus matrices with k=1-12.</p>
</sec>
<sec id="S21">
<title>Gene set enrichment analysis</title>
<p id="P47">Over-representation of biological gene sets in individual temporal gene clusters for RNA-seq and ribo-seq data were investigated using the R clusterProfiler package and enricher function (<xref ref-type="bibr" rid="R87">Yu et al., 2012</xref>). Gene sets were downloaded from the MSIG data bank via the msigdbr R-project package, including “Hallmark” and “GO:BP” (<xref ref-type="bibr" rid="R52">Liberzon et al., 2011</xref>, <xref ref-type="bibr" rid="R51">Liberzon et al., 2015</xref>, <xref ref-type="bibr" rid="R37">Jassal et al., 2020</xref>). Gene sets were considered significantly enriched in a cluster if adjusted q-values were &lt; 0.05.</p>
</sec>
<sec id="S22">
<title>Viral Counts</title>
<p id="P48">Viral read density plots were generated using the SAM file from viral genome alignment. The SAMtools (<xref ref-type="bibr" rid="R50">Li et al., 2009</xref>) package was used to create an mpileup file containing information about the read density, strandedness, mapping quality, and nucleotide identity at each position. Custom scripts (deposited at GitHub under kutluaylab) then were utilized to create files providing only the nucleotide identity and number of counts at each position for both sense and antisense reads. These were then visualized by scripts written in R.</p>
<p id="P49">As SARS-CoV-2 generates chimeric subgenomic mRNAs (sgRNAs) in addition to its genomic RNA (gRNA), featureCounts could not be used to accurately estimate viral gene counts from RNASeq due to the presence of nested 3’ sequences. Therefore, in order to visualize and enumerate such chimeric sequences the BWA aligner (<xref ref-type="bibr" rid="R49">Li and Durbin, 2009</xref>) was used in ‘mem’ mode on viral RNASeq reads. After generating this alignment using the default parameters and same reference SARS-CoV-2 FASTA file as above, chimeric reads were isolated by searching for all reads containing the ‘SA’ tag and the SARS TRS sequence, ‘AAACGAAC’. SARS-CoV-2 gRNAs were extracted by searching for all reads containing the first 15-20 bases of the ORF1A coding sequence (CDS), as these sequences would only be present in full-length SARS-CoV-2 genomes. This provided the sequences and alignment locations of the chimeric and genomic reads, which were then visualized using R. For sgRNAs, the viral gene corresponding to each transcript was determined by locating the CDS with the nearest downstream start site. This data, together with the number of gRNAs was used to calculate relative percentages of viral transcripts and, together with the total number of mapped viral reads, allowed for the tabulation of viral gene counts at each time point. For ribosome profiling data, featureCounts was used to enumerate the number of viral reads, as ribosomes only translate the first gene on each transcript and so footprints from nested 3’ gene were low enough to be negligible.</p>
</sec>
</sec>
<sec sec-type="supplementary-material" id="SM">
<title>Supplementary Material</title>
<supplementary-material content-type="local-data" id="SD1">
<label>Supplementary Figs</label>
<media xlink:href="EMS103742-supplement-Supplementary_Figs.pdf" mimetype="application" mime-subtype="pdf" id="N67592" position="anchor"/>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD2">
<label>Supplementary Figures and Tables Legends</label>
<media xlink:href="EMS103742-supplement-Supplementary_Figures_and_Tables_Legends.pdf" mimetype="application" mime-subtype="pdf" id="N67601" position="anchor"/>
</supplementary-material>
</sec>
</body>
<back>
<ack id="S23">
<title>Acknowledgements</title>
<p>We would like to thank members of the Diamond lab for reagents and support. This work was supported by Washington University startup funds for SBK, Andrew and Virginia Craig faculty fellowship for SBK, R21 AI145669 to SBK and JD, National Science Foundation Graduate Research Fellowship under Grant No. DGE-1745038 to KV, Stephen I. Morse postdoctoral fellowship to MPC, Helen Hay Whitney Foundation postdoctoral fellowship to J.B.C., and the Dorothy R. and Hubert C. Moog Professorship to SLB. All NGS data (48 sets of ribo-seq and 48 sets of matching RNA-seq) are deposited in the GEO database under GSE158930.</p>
</ack>
<fn-group>
<fn id="FN1" fn-type="con">
<p id="P50">
<bold>Author Contributions</bold> MPC, HRV, AH, TH, SGP, JBC, SBK conducted the experiments. KT, NL, YW, YL, WY conducted the bioinformatics analysis. HRV and SBK wrote the original manuscript with input from MSD, SLB, JD, JBC.</p>
</fn>
</fn-group>
<ref-list>
<ref id="R1">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Banerjee</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Blanco</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Bruce</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Honson</surname>
<given-names>DD</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Chow</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bhat</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ollikainen</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Quinodoz</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Loney</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Thai</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>
<article-title>SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses</article-title>
<source>Cell</source>
<year>2020</year>
<volume>183</volume>
<fpage>1325</fpage>
<lpage>1339</lpage>
<elocation-id>e21</elocation-id>
</element-citation>
</ref>
<ref id="R2">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baril</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Dulude</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Gendron</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Lemay</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Brakier-Gingras</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Efficiency of a programmed -1 ribosomal frameshift in the different subtypes of the human immunodeficiency virus type 1 group M</article-title>
<source>RNA</source>
<year>2003</year>
<volume>9</volume>
<fpage>1246</fpage>
<lpage>53</lpage>
</element-citation>
</ref>
<ref id="R3">
<element-citation publication-type="others">
<person-group person-group-type="author">
<name>
<surname>Beauparlant</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Lamaze</surname>
<given-names>FC</given-names>
</name>
<name>
<surname>Samb</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Lippens</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Deschenes</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Droit</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>metagene: A package to produce metagene plots</article-title>
<source>R package version 2.20.0</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R4">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhatt</surname>
<given-names>PR</given-names>
</name>
<name>
<surname>Scaiola</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Loughran</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Leibundgut</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kratzel</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Meurs</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Dreos</surname>
<given-names>R</given-names>
</name>
<name>
<surname>O’connor</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Mcmillan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bode</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Thiel</surname>
<given-names>V</given-names>
</name>
<etal/>
</person-group>
<article-title>Structural basis of ribosomal frameshifting during translation of the SARS-CoV-2 RNA genome</article-title>
<source>Science</source>
<year>2021</year>
<volume>372</volume>
<fpage>1306</fpage>
<lpage>1313</lpage>
</element-citation>
</ref>
<ref id="R5">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bidou</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Stahl</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Grima</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Cassan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rousset</surname>
<given-names>JP</given-names>
</name>
</person-group>
<article-title>In vivo HIV-1 frameshifting efficiency is directly related to the stability of the stem-loop stimulatory signal</article-title>
<source>RNA</source>
<year>1997</year>
<volume>3</volume>
<fpage>1153</fpage>
<lpage>8</lpage>
</element-citation>
</ref>
<ref id="R6">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Biswas</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Pacchia</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Dougherty</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Peltz</surname>
<given-names>SW</given-names>
</name>
</person-group>
<article-title>The human immunodeficiency virus type 1 ribosomal frameshifting site is an invariant sequence determinant and an important target for antiviral therapy</article-title>
<source>J Virol</source>
<year>2004</year>
<volume>78</volume>
<fpage>2082</fpage>
<lpage>7</lpage>
</element-citation>
</ref>
<ref id="R7">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blanco-Melo</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Nilsson-Payant</surname>
<given-names>BE</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>WC</given-names>
</name>
<name>
<surname>Uhl</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hoagland</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Moller</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Jordan</surname>
<given-names>TX</given-names>
</name>
<name>
<surname>Oishi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Panis</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sachs</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>TT</given-names>
</name>
<etal/>
</person-group>
<article-title>Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19</article-title>
<source>Cell</source>
<year>2020</year>
<volume>181</volume>
<fpage>1036</fpage>
<lpage>1045</lpage>
<elocation-id>e9</elocation-id>
</element-citation>
</ref>
<ref id="R8">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brierley</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Dos Ramos</surname>
<given-names>FJ</given-names>
</name>
</person-group>
<article-title>Programmed ribosomal frameshifting in HIV-1 and the SARS-CoV</article-title>
<source>Virus Res</source>
<year>2006</year>
<volume>119</volume>
<fpage>29</fpage>
<lpage>42</lpage>
</element-citation>
</ref>
<ref id="R9">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Butler</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Mozsary</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Meydan</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Danko</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Foox</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rosiene</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Shaiber</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Afshinnekoo</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Mackay</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sedlazeck</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Ivanov</surname>
<given-names>NA</given-names>
</name>
<etal/>
</person-group>
<article-title>Shotgun Transcriptome and Isothermal Profiling of SARS-CoV-2 Infection Reveals Unique Host Responses, Viral Diversification, and Drug Interactions</article-title>
<source>bioRxiv</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R10">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Sutthent</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Auewarakul</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Apichartpiyakul</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Essex</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>TH</given-names>
</name>
</person-group>
<article-title>Differential stability of the mRNA secondary structures in the frameshift site of various HIV type 1 viruses</article-title>
<source>AIDS Res Hum Retroviruses</source>
<year>1999</year>
<volume>15</volume>
<fpage>1591</fpage>
<lpage>6</lpage>
</element-citation>
</ref>
<ref id="R11">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Channappanavar</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Perlman</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology</article-title>
<source>Semin Immunopathol</source>
<year>2017</year>
<volume>39</volume>
<fpage>529</fpage>
<lpage>539</lpage>
</element-citation>
</ref>
<ref id="R12">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>KY</given-names>
</name>
<name>
<surname>Chou</surname>
<given-names>MY</given-names>
</name>
<name>
<surname>Bustamante</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Tinoco</surname>
<given-names>I</given-names>
<suffix>JR</suffix>
</name>
</person-group>
<article-title>Triplex structures in an RNA pseudoknot enhance mechanical stability and increase efficiency of-1 ribosomal frameshifting</article-title>
<source>Proc Natl Acad Sci U S A</source>
<year>2009</year>
<volume>106</volume>
<fpage>12706</fpage>
<lpage>11</lpage>
</element-citation>
</ref>
<ref id="R13">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Daffis</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Szretter</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Schriewer</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Youn</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Errett</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>TY</given-names>
</name>
<name>
<surname>Schneller</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zust</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Thiel</surname>
<given-names>V</given-names>
</name>
<etal/>
</person-group>
<article-title>2’-0 methylation of the viral mRNA cap evades host restriction by IFIT family members</article-title>
<source>Nature</source>
<year>2010</year>
<volume>468</volume>
<fpage>452</fpage>
<lpage>6</lpage>
</element-citation>
</ref>
<ref id="R14">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diamond</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Farzan</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>The broad-spectrum antiviral functions of IFIT and IFITM proteins</article-title>
<source>Nat Rev Immunol</source>
<year>2013</year>
<volume>13</volume>
<fpage>46</fpage>
<lpage>57</lpage>
</element-citation>
</ref>
<ref id="R15">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dinan</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Keep</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bickerton</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Britton</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Firth</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Brierley</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Comparative Analysis of Gene Expression in Virulent and Attenuated Strains of Infectious Bronchitis Virus at Subcodon Resolution</article-title>
<source>J Virol</source>
<year>2019</year>
<volume>93</volume>
</element-citation>
</ref>
<ref id="R16">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dinman</surname>
<given-names>JD</given-names>
</name>
</person-group>
<article-title>Mechanisms and implications of programmed translational frameshifting</article-title>
<source>Wiley Interdiscip Rev RNA</source>
<year>2012</year>
<volume>3</volume>
<fpage>661</fpage>
<lpage>73</lpage>
</element-citation>
</ref>
<ref id="R17">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dobin</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Schlesinger</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Drenkow</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zaleski</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Jha</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Batut</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Chaisson</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gingeras</surname>
<given-names>TR</given-names>
</name>
</person-group>
<article-title>STAR: ultrafast universal RNA-seq aligner</article-title>
<source>Bioinformatics</source>
<year>2013</year>
<volume>29</volume>
<fpage>15</fpage>
<lpage>21</lpage>
</element-citation>
</ref>
<ref id="R18">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dulude</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Berchiche</surname>
<given-names>YA</given-names>
</name>
<name>
<surname>Gendron</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Brakier-Gingras</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Heveker</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Decreasing the frameshift efficiency translates into an equivalent reduction of the replication of the human immunodeficiency virus type 1</article-title>
<source>Virology</source>
<year>2006</year>
<volume>345</volume>
<fpage>127</fpage>
<lpage>36</lpage>
</element-citation>
</ref>
<ref id="R19">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farabaugh</surname>
<given-names>PJ</given-names>
</name>
</person-group>
<article-title>Programmed translational frameshifting</article-title>
<source>Microbiol Rev</source>
<year>1996</year>
<volume>60</volume>
<fpage>103</fpage>
<lpage>34</lpage>
</element-citation>
</ref>
<ref id="R20">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fensterl</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Sen</surname>
<given-names>GC</given-names>
</name>
</person-group>
<article-title>Interferon-induced Ifit proteins: their role in viral pathogenesis</article-title>
<source>J Virol</source>
<year>2015</year>
<volume>89</volume>
<fpage>2462</fpage>
<lpage>8</lpage>
</element-citation>
</ref>
<ref id="R21">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Finkel</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Gluck</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Nachshon</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Winkler</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Fisher</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Rozman</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Mizrahi</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Lubelsky</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zuckerman</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Slobodin</surname>
<given-names>B</given-names>
</name>
<etal/>
</person-group>
<article-title>SARS-CoV-2 uses a multipronged strategy to impede host protein synthesis</article-title>
<source>Nature</source>
<year>2021</year>
<volume>594</volume>
<fpage>240</fpage>
<lpage>245</lpage>
</element-citation>
</ref>
<ref id="R22">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Finkel</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Mizrahi</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Nachshon</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Weingarten-Gabbay</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Morgenstern</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Yahalom-Ronen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Tamir</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Achdout</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Stein</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Israeli</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Beth-Din</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>The coding capacity of SARS-CoV-2</article-title>
<source>Nature</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R23">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garcia-Miranda</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Becker</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Benner</surname>
<given-names>BE</given-names>
</name>
<name>
<surname>Blume</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sherer</surname>
<given-names>NM</given-names>
</name>
<name>
<surname>Butcher</surname>
<given-names>SE</given-names>
</name>
</person-group>
<article-title>Stability of HIV Frameshift Site RNA Correlates with Frameshift Efficiency and Decreased Virus Infectivity</article-title>
<source>J Virol</source>
<year>2016</year>
<volume>90</volume>
<fpage>6906</fpage>
<lpage>6917</lpage>
</element-citation>
</ref>
<ref id="R24">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Giedroc</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Cornish</surname>
<given-names>PV</given-names>
</name>
</person-group>
<article-title>Frameshifting RNA pseudoknots: structure and mechanism</article-title>
<source>Virus Res</source>
<year>2009</year>
<volume>139</volume>
<fpage>193</fpage>
<lpage>208</lpage>
</element-citation>
</ref>
<ref id="R25">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hansen</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Reihani</surname>
<given-names>SN</given-names>
</name>
<name>
<surname>Oddershede</surname>
<given-names>LB</given-names>
</name>
<name>
<surname>Sorensen</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>Correlation between mechanical strength of messenger RNA pseudoknots and ribosomal frameshifting</article-title>
<source>Proc Natl Acad Sci U S A</source>
<year>2007</year>
<volume>104</volume>
<fpage>5830</fpage>
<lpage>5</lpage>
</element-citation>
</ref>
<ref id="R26">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Horani</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Druley</surname>
<given-names>TE</given-names>
</name>
<name>
<surname>Zariwala</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Levinson</surname>
<given-names>BT</given-names>
</name>
<name>
<surname>Van Arendonk</surname>
<given-names>LG</given-names>
</name>
<name>
<surname>Thornton</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Giacalone</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Albee</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>EH</given-names>
</name>
<etal/>
</person-group>
<article-title>Whole-exome capture and sequencing identifies HEATR2 mutation as a cause of primary ciliary dyskinesia</article-title>
<source>Am J Hum Genet</source>
<year>2012</year>
<volume>91</volume>
<fpage>685</fpage>
<lpage>93</lpage>
</element-citation>
</ref>
<ref id="R27">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Horani</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ustione</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Firth</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gunsten</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Haspel</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Piston</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Brody</surname>
<given-names>SL</given-names>
</name>
</person-group>
<article-title>Establishment of the early cilia preassembly protein complex during motile ciliogenesis</article-title>
<source>Proc Natl Acad Sci U SA</source>
<year>2018</year>
<volume>115</volume>
<fpage>E1221</fpage>
<lpage>E1228</lpage>
</element-citation>
</ref>
<ref id="R28">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hume</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Abo</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Werder</surname>
<given-names>RB</given-names>
</name>
<name>
<surname>Villacorta-Martin</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Alysandratos</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>Beermann</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Simone-Roach</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Olejnik</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Suder</surname>
<given-names>EL</given-names>
</name>
<name>
<surname>Bullitt</surname>
<given-names>E</given-names>
</name>
<etal/>
</person-group>
<article-title>SARS-CoV-2 Infection of Pluripotent Stem Cell-derived Human Lung Alveolar Type 2 Cells Elicits a Rapid Epithelial-Intrinsic Inflammatory Response</article-title>
<source>bioRxiv</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R29">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>Highly conserved RNA pseudoknots at the Gag-Pol junction of HIV-1 suggest a novel mechanism of - 1 ribosomal frameshifting</article-title>
<source>RNA</source>
<year>2014</year>
<volume>20</volume>
<fpage>587</fpage>
<lpage>93</lpage>
</element-citation>
</ref>
<ref id="R30">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hyde</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Diamond</surname>
<given-names>MS</given-names>
</name>
</person-group>
<article-title>Innate immune restriction and antagonism of viral RNA lacking 2-O methylation</article-title>
<source>Virology</source>
<year>2015</year>
<volume>479</volume>
<issue>480</issue>
<fpage>66</fpage>
<lpage>74</lpage>
</element-citation>
</ref>
<ref id="R31">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ingolia</surname>
<given-names>NT</given-names>
</name>
<name>
<surname>Brar</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Rouskin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mcgeachy</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Weissman</surname>
<given-names>JS</given-names>
</name>
</person-group>
<article-title>The ribosome profiling strategy for monitoring translation in vivo by deep sequencing of ribosome-protected mRNA fragments</article-title>
<source>Nat Protoc</source>
<year>2012</year>
<volume>7</volume>
<fpage>1534</fpage>
<lpage>50</lpage>
</element-citation>
</ref>
<ref id="R32">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ingolia</surname>
<given-names>NT</given-names>
</name>
<name>
<surname>Ghaemmaghami</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Newman</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Weissman</surname>
<given-names>JS</given-names>
</name>
</person-group>
<article-title>Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling</article-title>
<source>Science</source>
<year>2009</year>
<volume>324</volume>
<fpage>218</fpage>
<lpage>23</lpage>
</element-citation>
</ref>
<ref id="R33">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Irigoyen</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Firth</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>BY</given-names>
</name>
<name>
<surname>Siddell</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Brierley</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>High-Resolution Analysis of Coronavirus Gene Expression by RNA Sequencing and Ribosome Profiling</article-title>
<source>PLoS Pathog</source>
<year>2016</year>
<volume>12</volume>
<elocation-id>e1005473</elocation-id>
</element-citation>
</ref>
<ref id="R34">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jacks</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Power</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Masiarz</surname>
<given-names>FR</given-names>
</name>
<name>
<surname>Luciw</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Barr</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Varmus</surname>
<given-names>HE</given-names>
</name>
</person-group>
<article-title>Characterization of ribosomal frameshifting in HIV-1 gag-pol expression</article-title>
<source>Nature</source>
<year>1988</year>
<volume>331</volume>
<fpage>280</fpage>
<lpage>3</lpage>
</element-citation>
</ref>
<ref id="R35">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jafarzadeh</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Chauhan</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Saha</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Jafarzadeh</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nemati</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions</article-title>
<source>Life Sci</source>
<year>2020</year>
<elocation-id>118102</elocation-id>
</element-citation>
</ref>
<ref id="R36">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>James</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Smyth</surname>
<given-names>JW</given-names>
</name>
</person-group>
<article-title>Alternative mechanisms of translation initiation: An emerging dynamic regulator of the proteome in health and disease</article-title>
<source>Life Sci</source>
<year>2018</year>
<volume>212</volume>
<fpage>138</fpage>
<lpage>144</lpage>
</element-citation>
</ref>
<ref id="R37">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jassal</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Matthews</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Viteri</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Gong</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lorente</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Fabregat</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sidiropoulos</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Cook</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gillespie</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Haw</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group>
<article-title>The reactome pathway knowledgebase</article-title>
<source>Nucleic Acids Res</source>
<year>2020</year>
<volume>48</volume>
<fpage>D498</fpage>
<lpage>D503</lpage>
</element-citation>
</ref>
<ref id="R38">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kharytonchyk</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Monti</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Smaldino</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Van</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Bolden</surname>
<given-names>NC</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Russo</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Swanson</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Shuey</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Telesnitsky</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>
<article-title>Transcriptional start site heterogeneity modulates the structure and function of the HIV-1 genome</article-title>
<source>Proc Natl Acad Sci U S A</source>
<year>2016</year>
<volume>113</volume>
<fpage>13378</fpage>
<lpage>13383</lpage>
</element-citation>
</ref>
<ref id="R39">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>VN</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>The Architecture of SARS-CoV-2 Transcriptome</article-title>
<source>Cell</source>
<year>2020</year>
<volume>181</volume>
<fpage>914</fpage>
<lpage>921</lpage>
<elocation-id>e10</elocation-id>
</element-citation>
</ref>
<ref id="R40">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Konno</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kimura</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Uriu</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Fukushi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Irie</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Koyanagi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Sauter</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Gifford</surname>
<given-names>RJ</given-names>
</name>
<collab>Consortium, U-C</collab>
<name>
<surname>Nakagawa</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group>
<article-title>SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant</article-title>
<source>Cell Rep</source>
<year>2020</year>
<volume>32</volume>
<elocation-id>108185</elocation-id>
</element-citation>
</ref>
<ref id="R41">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Korniy</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Samatova</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Anokhina</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Peske</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Rodnina</surname>
<given-names>MV</given-names>
</name>
</person-group>
<article-title>Mechanisms and biomedical implications of -1 programmed ribosome frameshifting on viral and bacterial mRNAs</article-title>
<source>FEBS Lett</source>
<year>2019</year>
<volume>593</volume>
<fpage>1468</fpage>
<lpage>1482</lpage>
</element-citation>
</ref>
<ref id="R42">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kutluay</surname>
<given-names>SB</given-names>
</name>
<name>
<surname>Bieniasz</surname>
<given-names>PD</given-names>
</name>
</person-group>
<article-title>Analysis of HIV-1 Gag-RNA Interactions in Cells and Virions by CLIP-seq</article-title>
<source>Methods Mol Biol</source>
<year>2016</year>
<volume>1354</volume>
<fpage>119</fpage>
<lpage>31</lpage>
</element-citation>
</ref>
<ref id="R43">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kutluay</surname>
<given-names>SB</given-names>
</name>
<name>
<surname>Zang</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Blanco-Melo</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Powell</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Jannain</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Errando</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bieniasz</surname>
<given-names>PD</given-names>
</name>
</person-group>
<article-title>Global changes in the RNA binding specificity of HIV-1 gag regulate virion genesis</article-title>
<source>Cell</source>
<year>2014</year>
<volume>159</volume>
<fpage>1096</fpage>
<lpage>1109</lpage>
</element-citation>
</ref>
<ref id="R44">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kwan</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>SR</given-names>
</name>
</person-group>
<article-title>Noncanonical Translation Initiation in Eukaryotes</article-title>
<source>Cold Spring Harb Perspect Biol</source>
<year>2019</year>
<fpage>11</fpage>
</element-citation>
</ref>
<ref id="R45">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Langmead</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Trapnell</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Pop</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Salzberg</surname>
<given-names>SL</given-names>
</name>
</person-group>
<article-title>Ultrafast and memory-efficient alignment of short DNA sequences to the human genome</article-title>
<source>Genome Biol</source>
<year>2009</year>
<volume>10</volume>
<fpage>R25</fpage>
</element-citation>
</ref>
<ref id="R46">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lapointe</surname>
<given-names>CP</given-names>
</name>
<name>
<surname>Grosely</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fernandez</surname>
<given-names>IS</given-names>
</name>
<name>
<surname>Puglisi</surname>
<given-names>JD</given-names>
</name>
</person-group>
<article-title>Dynamic competition between SARS-CoV-2 NSP1 and mRNA on the human ribosome inhibits translation initiation</article-title>
<source>Proc Natl Acad Sci U S A</source>
<year>2021</year>
<volume>118</volume>
</element-citation>
</ref>
<ref id="R47">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lauria</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Tebaldi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Bernabo</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Groen</surname>
<given-names>EJN</given-names>
</name>
<name>
<surname>Gillingwater</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Viero</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>riboWaltz: Optimization of ribosome P-site positioning in ribosome profiling data</article-title>
<source>PLoS Comput Biol</source>
<year>2018</year>
<volume>14</volume>
<elocation-id>e1006169</elocation-id>
</element-citation>
</ref>
<ref id="R48">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lei</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group>
<article-title>Activation and evasion of type I interferon responses by SARS-CoV-2</article-title>
<source>Nat Commun</source>
<year>2020</year>
<volume>11</volume>
<fpage>3810</fpage>
</element-citation>
</ref>
<ref id="R49">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Durbin</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Fast and accurate short read alignment with Burrows-Wheeler transform</article-title>
<source>Bioinformatics</source>
<year>2009</year>
<volume>25</volume>
<fpage>1754</fpage>
<lpage>60</lpage>
</element-citation>
</ref>
<ref id="R50">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Handsaker</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Wysoker</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fennell</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ruan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Homer</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Marth</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Abecasis</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Durbin</surname>
<given-names>R</given-names>
</name>
<collab>Genome project data processing, S</collab>
</person-group>
<article-title>The Sequence Alignment/Map format and SAMtools</article-title>
<source>Bioinformatics</source>
<year>2009</year>
<volume>25</volume>
<fpage>2078</fpage>
<lpage>9</lpage>
</element-citation>
</ref>
<ref id="R51">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liberzon</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Birger</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Thorvaldsdottir</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ghandi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mesirov</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Tamayo</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>The Molecular Signatures Database (MSigDB) hallmark gene set collection</article-title>
<source>Cell Syst</source>
<year>2015</year>
<volume>1</volume>
<fpage>417</fpage>
<lpage>425</lpage>
</element-citation>
</ref>
<ref id="R52">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liberzon</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Subramanian</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pinchback</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Thorvaldsdottir</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Tamayo</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Mesirov</surname>
<given-names>JP</given-names>
</name>
</person-group>
<article-title>Molecular signatures database (MSigDB) 3.0</article-title>
<source>Bioinformatics</source>
<year>2011</year>
<volume>27</volume>
<fpage>1739</fpage>
<lpage>40</lpage>
</element-citation>
</ref>
<ref id="R53">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lokugamage</surname>
<given-names>KG</given-names>
</name>
<name>
<surname>Hage</surname>
<given-names>A</given-names>
</name>
<name>
<surname>De Vries</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Valero-Jimenez</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Schindewolf</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Dittmann</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rajsbaum</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Menachery</surname>
<given-names>VD</given-names>
</name>
</person-group>
<article-title>Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV</article-title>
<source>J Virol</source>
<year>2020</year>
<volume>94</volume>
</element-citation>
</ref>
<ref id="R54">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Masters</surname>
<given-names>PS</given-names>
</name>
</person-group>
<article-title>The molecular biology of coronaviruses</article-title>
<source>Adv Virus Res</source>
<year>2006</year>
<volume>66</volume>
<fpage>193</fpage>
<lpage>292</lpage>
</element-citation>
</ref>
<ref id="R55">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Menachery</surname>
<given-names>VD</given-names>
</name>
<name>
<surname>Eisfeld</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Schafer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Josset</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Sims</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Proll</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Neumann</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Tilton</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>
<article-title>Pathogenic influenza viruses and coronaviruses utilize similar and contrasting approaches to control interferon-stimulated gene responses</article-title>
<source>mBio</source>
<year>2014</year>
<volume>5</volume>
<elocation-id>e01174-14</elocation-id>
</element-citation>
</ref>
<ref id="R56">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miorin</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Kehrer</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Sanchez-Aparicio</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Cupic</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Makio</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Mei</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Moreno</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Danziger</surname>
<given-names>O</given-names>
</name>
<etal/>
</person-group>
<article-title>SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling</article-title>
<source>Proc Natl Acad Sci U S A</source>
<year>2020</year>
<volume>117</volume>
<fpage>28344</fpage>
<lpage>28354</lpage>
</element-citation>
</ref>
<ref id="R57">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mitchell</surname>
<given-names>HD</given-names>
</name>
<name>
<surname>Eisfeld</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Sims</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Mcdermott</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Matzke</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Webb-Robertson</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Tilton</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Tchitchek</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Josset</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ellis</surname>
<given-names>AL</given-names>
</name>
<etal/>
</person-group>
<article-title>A network integration approach to predict conserved regulators related to pathogenicity of influenza and SARS-CoV respiratory viruses</article-title>
<source>PLoS One</source>
<year>2013</year>
<volume>8</volume>
<elocation-id>e69374</elocation-id>
</element-citation>
</ref>
<ref id="R58">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mouzakis</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>Lang</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Vander Meulen</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Easterday</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>Butcher</surname>
<given-names>SE</given-names>
</name>
</person-group>
<article-title>HIV-1 frameshift efficiency is primarily determined by the stability of base pairs positioned at the mRNA entrance channel of the ribosome</article-title>
<source>Nucleic Acids Res</source>
<year>2013</year>
<volume>41</volume>
<fpage>1901</fpage>
<lpage>13</lpage>
</element-citation>
</ref>
<ref id="R59">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakagawa</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Lokugamage</surname>
<given-names>KG</given-names>
</name>
<name>
<surname>Makino</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Viral and Cellular mRNA Translation in Coronavirus-Infected Cells</article-title>
<source>Adv Virus Res</source>
<year>2016</year>
<volume>96</volume>
<fpage>165</fpage>
<lpage>192</lpage>
</element-citation>
</ref>
<ref id="R60">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Narayanan</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ramirez</surname>
<given-names>SI</given-names>
</name>
<name>
<surname>Lokugamage</surname>
<given-names>KG</given-names>
</name>
<name>
<surname>Makino</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Coronavirus nonstructural protein 1: Common and distinct functions in the regulation of host and viral gene expression</article-title>
<source>Virus Res</source>
<year>2015</year>
<volume>202</volume>
<fpage>89</fpage>
<lpage>100</lpage>
</element-citation>
</ref>
<ref id="R61">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parkin</surname>
<given-names>NT</given-names>
</name>
<name>
<surname>Chamorro</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Varmus</surname>
<given-names>HE</given-names>
</name>
</person-group>
<article-title>Human immunodeficiency virus type 1 gag-pol frameshifting is dependent on downstream mRNA secondary structure: demonstration by expression in vivo</article-title>
<source>J Virol</source>
<year>1992</year>
<volume>66</volume>
<fpage>5147</fpage>
<lpage>51</lpage>
</element-citation>
</ref>
<ref id="R62">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perlman</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dandekar</surname>
<given-names>AA</given-names>
</name>
</person-group>
<article-title>Immunopathogenesis of coronavirus infections: implications for SARS</article-title>
<source>Nat Rev Immunol</source>
<year>2005</year>
<volume>5</volume>
<fpage>917</fpage>
<lpage>27</lpage>
</element-citation>
</ref>
<ref id="R63">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Plant</surname>
<given-names>EP</given-names>
</name>
<name>
<surname>Dinman</surname>
<given-names>JD</given-names>
</name>
</person-group>
<article-title>The role of programmed-1 ribosomal frameshifting in coronavirus propagation</article-title>
<source>Front Biosci</source>
<year>2008</year>
<volume>13</volume>
<fpage>4873</fpage>
<lpage>81</lpage>
</element-citation>
</ref>
<ref id="R64">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Plant</surname>
<given-names>EP</given-names>
</name>
<name>
<surname>Jacobs</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Harger</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Meskauskas</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Jacobs</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Baxter</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Petrov</surname>
<given-names>AN</given-names>
</name>
<name>
<surname>Dinman</surname>
<given-names>JD</given-names>
</name>
</person-group>
<article-title>The 9-A solution: how mRNA pseudoknots promote efficient programmed -1 ribosomal frameshifting</article-title>
<source>RNA</source>
<year>2003</year>
<volume>9</volume>
<fpage>168</fpage>
<lpage>74</lpage>
</element-citation>
</ref>
<ref id="R65">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Puray-Chavez</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lapak</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Schrank</surname>
<given-names>TP</given-names>
</name>
<name>
<surname>Elliott</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Bhatt</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Agajanian</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Jasuja</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Lawson</surname>
<given-names>DQ</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Rothlauf</surname>
<given-names>PW</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z</given-names>
</name>
<etal/>
</person-group>
<article-title>Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell</article-title>
<source>Cell Rep</source>
<year>2021</year>
<volume>36</volume>
<elocation-id>109364</elocation-id>
</element-citation>
</ref>
<ref id="R66">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rao</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hoskins</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Tonn</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Garcia</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ozadam</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Sarinay Cenik</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Cenik</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Genes with 5’ terminal oligopyrimidine tracts preferentially escape global suppression of translation by the SARS-CoV-2 NSP1 protein</article-title>
<source>RNA</source>
<year>2021</year>
</element-citation>
</ref>
<ref id="R67">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ravindra</surname>
<given-names>NG</given-names>
</name>
<name>
<surname>Alfajaro</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Gasque</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Huston</surname>
<given-names>NC</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Szigeti-Buck</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yasumoto</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Greaney</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Habet</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Chow</surname>
<given-names>RD</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>JS</given-names>
</name>
<etal/>
</person-group>
<article-title>Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes</article-title>
<source>PLoS Biol</source>
<year>2021</year>
<volume>19</volume>
<elocation-id>e3001143</elocation-id>
</element-citation>
</ref>
<ref id="R68">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reynaud</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>DY</given-names>
</name>
<name>
<surname>Atasheva</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rasalouskaya</surname>
<given-names>A</given-names>
</name>
<name>
<surname>White</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Diamond</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Weaver</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Frolova</surname>
<given-names>EI</given-names>
</name>
<name>
<surname>Frolov</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>IFIT1 Differentially Interferes with Translation and Replication of Alphavirus Genomes and Promotes Induction of Type I Interferon</article-title>
<source>PLoS Pathog</source>
<year>2015</year>
<volume>11</volume>
<elocation-id>e1004863</elocation-id>
</element-citation>
</ref>
<ref id="R69">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robinson</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Mccarthy</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Smyth</surname>
<given-names>GK</given-names>
</name>
</person-group>
<article-title>edgeR: a Bioconductor package for differential expression analysis of digital gene expression data</article-title>
<source>Bioinformatics</source>
<year>2010</year>
<volume>26</volume>
<fpage>139</fpage>
<lpage>40</lpage>
</element-citation>
</ref>
<ref id="R70">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sa Ribero</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jouvenet</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Dreux</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nisole</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Interplay between SARS-CoV-2 and the type I interferon response</article-title>
<source>PLoS Pathog</source>
<year>2020</year>
<volume>16</volume>
<elocation-id>e1008737</elocation-id>
</element-citation>
</ref>
<ref id="R71">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schaefer</surname>
<given-names>IM</given-names>
</name>
<name>
<surname>Padera</surname>
<given-names>RF</given-names>
</name>
<name>
<surname>Solomon</surname>
<given-names>IH</given-names>
</name>
<name>
<surname>Kanjilal</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hammer</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Hornick</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Sholl</surname>
<given-names>LM</given-names>
</name>
</person-group>
<article-title>In situ detection of SARS-CoV-2 in lungs and airways of patients with COVID-19</article-title>
<source>Mod Pathol</source>
<year>2020</year>
<volume>33</volume>
<fpage>2104</fpage>
<lpage>2114</lpage>
</element-citation>
</ref>
<ref id="R72">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schubert</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Karousis</surname>
<given-names>ED</given-names>
</name>
<name>
<surname>Jomaa</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Scaiola</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Echeverria</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Gurzeler</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Leibundgut</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Thiel</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Muhlemann</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Ban</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation</article-title>
<source>Nat Struct Mol Biol</source>
<year>2020</year>
<volume>27</volume>
<fpage>959</fpage>
<lpage>966</lpage>
</element-citation>
</ref>
<ref id="R73">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shehu-Xhilaga</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Crowe</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Mak</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Maintenance of the Gag/Gag-Pol ratio is important for human immunodeficiency virus type 1 RNA dimerization and viral infectivity</article-title>
<source>J Virol</source>
<year>2001</year>
<volume>75</volume>
<fpage>1834</fpage>
<lpage>41</lpage>
</element-citation>
</ref>
<ref id="R74">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Staple</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Butcher</surname>
<given-names>SE</given-names>
</name>
</person-group>
<article-title>Solution structure and thermodynamic investigation of the HIV-1 frameshift inducing element</article-title>
<source>J Mol Biol</source>
<year>2005</year>
<volume>349</volume>
<fpage>1011</fpage>
<lpage>23</lpage>
</element-citation>
</ref>
<ref id="R75">
<element-citation publication-type="others">
<person-group person-group-type="author">
<name>
<surname>Tenenbaum</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>KEGGREST: Client-side REST access to KEGG</article-title>
<source>R package version 1.6.4</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R76">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thoms</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Buschauer</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ameismeier</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Koepke</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Denk</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hirschenberger</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kratzat</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hayn</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mackens-Kiani</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Straub</surname>
<given-names>JH</given-names>
</name>
<etal/>
</person-group>
<article-title>Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2</article-title>
<source>Science</source>
<year>2020</year>
<volume>369</volume>
<fpage>1249</fpage>
<lpage>1255</lpage>
</element-citation>
</ref>
<ref id="R77">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tidu</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Janvier</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Schaeffer</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Sosnowski</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kuhn</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Hammann</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Westhof</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Eriani</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>The viral protein NSP1 acts as a ribosome gatekeeper for shutting down host translation and fostering SARS-CoV-2 translation</article-title>
<source>RNA</source>
<year>2020</year>
</element-citation>
</ref>
<ref id="R78">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Xuan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Goff</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Regulation of HIV-1 Gag-Pol Expression by Shiftless, an Inhibitor of Programmed -1 Ribosomal Frameshifting</article-title>
<source>Cell</source>
<year>2019</year>
<volume>176</volume>
<fpage>625</fpage>
<lpage>635</lpage>
<elocation-id>e14</elocation-id>
</element-citation>
</ref>
<ref id="R79">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weiss</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Navas-Martin</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus</article-title>
<source>Microbiol Mol Biol Rev</source>
<year>2005</year>
<volume>69</volume>
<fpage>635</fpage>
<lpage>64</lpage>
</element-citation>
</ref>
<ref id="R80">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilk</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Rustagi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>NQ</given-names>
</name>
<name>
<surname>Roque</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Martinez-Colon</surname>
<given-names>GJ</given-names>
</name>
<name>
<surname>Mckechnie</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Ivison</surname>
<given-names>GT</given-names>
</name>
<name>
<surname>Ranganath</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Vergara</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Hollis</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Simpson</surname>
<given-names>LJ</given-names>
</name>
<etal/>
</person-group>
<article-title>A single-cell atlas of the peripheral immune response in patients with severe COVID-19</article-title>
<source>Nat Med</source>
<year>2020</year>
<volume>26</volume>
<fpage>1070</fpage>
<lpage>1076</lpage>
</element-citation>
</ref>
<ref id="R81">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilkerson</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Hayes</surname>
<given-names>DN</given-names>
</name>
</person-group>
<article-title>ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking</article-title>
<source>Bioinformatics</source>
<year>2010</year>
<volume>26</volume>
<fpage>1572</fpage>
<lpage>3</lpage>
</element-citation>
</ref>
<ref id="R82">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilson</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Braddock</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Adams</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Rathjen</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>Kingsman</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Kingsman</surname>
<given-names>AJ</given-names>
</name>
</person-group>
<article-title>HIV expression strategies: ribosomal frameshifting is directed by a short sequence in both mammalian and yeast systems</article-title>
<source>Cell</source>
<year>1988</year>
<volume>55</volume>
<fpage>1159</fpage>
<lpage>69</lpage>
</element-citation>
</ref>
<ref id="R83">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xia</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Menachery</surname>
<given-names>VD</given-names>
</name>
<name>
<surname>Rajs Baum</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>PY</given-names>
</name>
</person-group>
<article-title>Evasion of Type I Interferon by SARS-CoV-2</article-title>
<source>Cell Rep</source>
<year>2020</year>
<volume>33</volume>
<elocation-id>108234</elocation-id>
</element-citation>
</ref>
<ref id="R84">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xie</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Muruato</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lokugamage</surname>
<given-names>KG</given-names>
</name>
<name>
<surname>Narayanan</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Schindewolf</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bopp</surname>
<given-names>NE</given-names>
</name>
<name>
<surname>Aguilar</surname>
<given-names>PV</given-names>
</name>
<name>
<surname>Plante</surname>
<given-names>KS</given-names>
</name>
<etal/>
</person-group>
<article-title>An Infectious cDNA Clone of SARS-CoV-2</article-title>
<source>Cell Host Microbe</source>
<year>2020</year>
<volume>27</volume>
<fpage>841</fpage>
<lpage>848</lpage>
<elocation-id>e3</elocation-id>
</element-citation>
</ref>
<ref id="R85">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>You</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Richer</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Brody</surname>
<given-names>SL</given-names>
</name>
</person-group>
<article-title>Growth and differentiation of mouse tracheal epithelial cells: selection of a proliferative population</article-title>
<source>Am J Physiol Lung Cell Mol Physiol</source>
<year>2002</year>
<volume>283</volume>
<elocation-id>LI315-21</elocation-id>
</element-citation>
</ref>
<ref id="R86">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Young</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Wakefield</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Smyth</surname>
<given-names>GK</given-names>
</name>
<name>
<surname>Oshlack</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Gene ontology analysis for RNA-seq: accounting for selection bias</article-title>
<source>Genome Biol</source>
<year>2010</year>
<volume>11</volume>
<fpage>R14</fpage>
</element-citation>
</ref>
<ref id="R87">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>LG</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>He</surname>
<given-names>QY</given-names>
</name>
</person-group>
<article-title>clusterProfiler: an R package for comparing biological themes among gene clusters</article-title>
<source>OMICS</source>
<year>2012</year>
<volume>16</volume>
<fpage>284</fpage>
<lpage>7</lpage>
</element-citation>
</ref>
<ref id="R88">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>P</given-names>
</name>
<name>
<surname>He</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>BF</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Ehli</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>F</given-names>
</name>
<etal/>
</person-group>
<article-title>Genome-wide identification and differential analysis of translational initiation</article-title>
<source>Nat Commun</source>
<year>2017</year>
<volume>8</volume>
<fpage>1749</fpage>
</element-citation>
</ref>
<ref id="R89">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ling</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Yi</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>
<article-title>Viral and host factors related to the clinical outcome of COVID-19</article-title>
<source>Nature</source>
<year>2020</year>
<volume>583</volume>
<fpage>437</fpage>
<lpage>440</lpage>
</element-citation>
</ref>
<ref id="R90">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group>
<article-title>Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients</article-title>
<source>Cell Host Microbe</source>
<year>2020</year>
<volume>27</volume>
<fpage>883</fpage>
<lpage>890</lpage>
<elocation-id>e2</elocation-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<title>Ribo-seq reveals the translational program of SARS-CoV-2.</title>
</caption>
<p>(A) Schematic diagram of Ribo-seq and RNA-seq experiments conducted in this study. Vero E6 cells were infected at 2 pfu/cell and cells were processed for RNA-seq and Ribo-seq at 2, 6, 12 and 24 hpi. (B) Percentage of RNA-seq and Ribo-seq reads uniquely mapping to SARS-CoV-2 and cellular transcripts at the indicated time points post infection. Individual data points indicate independent biological replicates. (C) Ribo-seq counts along the viral genome across various time points. Schematic diagram of SARS2 genome features shown above is co-linear (also see <xref ref-type="supplementary-material" rid="SD1">Table S3</xref>). (D) Translation efficiency of viral (red) vs. host mRNAs (grey circles) are shown. (E) Ribo-seq read counts within the frameshifting site across three independent replicates is shown at 6, 12 and 24 hpi. (F) Data show the SARS-CoV-2 frameshifting efficiency as determined by comparing the average read densities between ORF1a and ORF1b regions across three independent replicates and various time points post-infection.</p>
<graphic xlink:href="EMS103742-f001"/>
</fig>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption>
<title>Ribo-seq in HIV-1-infected cells reveals inefficient ribosomal frameshifting.</title>
</caption>
<p>Primary CD4+ T-cells were infected with HIV-1<sub>NL4-3</sub>/VSV-G at an MOI of 2 and infected cells processed for RNA-seq and Ribo-seq at 24 hpi. (A) Ribo-seq and RNA-seq reads (counts) mapping to the HIV-1 genome are shown. Schematic diagram of HIV-1 genome features shown below is co-linear (also see <xref ref-type="supplementary-material" rid="SD1">Table S7</xref>). (B) Secondary structure prediction of the HIV-1 ribosome frameshifting element is shown. (C) Ribosome occupancy within the frameshifting site is illustrated. (D) Translation efficiency of viral (red) vs. host mRNAs (grey circles) is shown.</p>
<graphic xlink:href="EMS103742-f002"/>
</fig>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption>
<title>Ribo-seq in primary airway cells reveals a more restrictive translational program for SARS-CoV-2.</title>
</caption>
<p>(A) Schematic diagram of Ribo-seq and RNA-seq experiments conducted in this study. HBECs grown at ALI were infected at 1 pfu/cell and cells were processed for RNA-seq and Ribo-seq at 4, 24, 48, 72 and 96 hpi. (B) Percentage of RNA-seq and Ribo-seq reads uniquely mapping to SARS-CoV-2 and cellular transcripts at the indicated time points post infection. Individual data points indicate independent biological replicates. (C) Fraction of RNA-seq and ribo-seq-derived reads mapping to 5’UTRs, CDSs and 3’UTRs is shown. (D) Ribo-seq counts along the viral genome across various time points. Schematic diagram of SARS2 genome features shown above is co-linear (<bold>also see</bold> <xref ref-type="supplementary-material" rid="SD1">Table S10</xref>).</p>
<graphic xlink:href="EMS103742-f003"/>
</fig>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption>
<title>SARS-CoV-2 infection induces translational repression of innate immune genes.</title>
</caption>
<p>Vero E6 cells infected at 2 pfu/cell as detailed in <xref ref-type="fig" rid="F1">Fig.1</xref> were analyzed for differential expression of host genes by RNA-seq (A, B) and ribo-seq (C, D). (A, C) Hierarchical clustering of differentially expressed genes (DEGs) after infection are shown. Genes were filtered for an absolute log<sub>2</sub> fold change &gt;2 and adjusted q-value &lt;0.05 at any time point. (B, D) Hypergeometric enrichment analysis from two different databases for each individual cluster in 4A and 4C (Hallmark, Gene Ontology). Color represents significance (q-value); size indicates the percentage of the cluster represented in the pathway. (Also see <xref ref-type="supplementary-material" rid="SD1">Table S11</xref>, <xref ref-type="supplementary-material" rid="SD1">S12</xref>).</p>
<graphic xlink:href="EMS103742-f004"/>
</fig>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption>
<title>SARS-CoV-2-induced changes in primary airway cells.</title>
</caption>
<p>Primary human bronchial epithelial cells grown at air-liquid interface were infected at 1 pfu/cell as detailed in <xref ref-type="fig" rid="F3">Fig.3</xref> were analyzed for differential expression of host genes by RNA-seq (A, B) and ribo-seq (C, D). (A, C) Hierarchical clustering of differentially expressed genes (DEGs) after infection are shown. Genes were filtered for an absolute log<sub>2</sub> fold change &gt;2 and adjusted q-value &lt;0.05 at any time point. (B, D) Hypergeometric enrichment analysis from two different databases for each individual cluster in 4A and 4C (Hallmark, Gene Ontology). Color represents significance (q-value); size indicates the percentage of the cluster represented in the pathway (see also <xref ref-type="supplementary-material" rid="SD1">Table S15</xref>, <xref ref-type="supplementary-material" rid="SD1">S16</xref>).</p>
<graphic xlink:href="EMS103742-f005"/>
</fig>
<fig id="F6" position="float">
<label>Figure 6</label>
<caption>
<title>SARS-CoV-2-induces translational repression of innate immune genes.</title>
</caption>
<p>Changes in the translational efficiency of genes that were differentially transcribed in response to SARS-CoV-2 infection are shown for Vero E6 cells (A-D) and HBECs (E-H) at the indicated time points post-infection (see also <xref ref-type="supplementary-material" rid="SD1">Table S17</xref>, <xref ref-type="supplementary-material" rid="SD1">18</xref>).</p>
<graphic xlink:href="EMS103742-f006"/>
</fig>
<fig id="F7" position="float">
<label>Figure 7</label>
<caption>
<title>SARS-CoV-2 proteins block the type-I IFN response at different stages.</title>
</caption>
<p>HEK293T cells were transfected with nsp1, nsp7, ORF3a and ORF6 expression plasmids and treated with 1000 u of IFN-alpha. Cells were analyzed for ISG induction by immunoblotting (A, B) and q-RT-PCR (C). Data are derived from two independent experiments. Error bars in B, C show the mean.</p>
<graphic xlink:href="EMS103742-f007"/>
</fig>
</floats-group>
</article>
